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Summary 
 
Tuberculosis (TB) is an infectious disease caused by the micro-organism Mycobacterium 
tuberculosis (MTB) that currently represents a global health emergency with around 9 million 
people affected and nearly 2 million deaths each year. The present therapeutic treatment for TB 
consists in the use of multiple anti-mycobacterial drugs such as rifampicin and isoniazid. This 
treatment is carried out for a long time leading to the onset of drug- and multidrug-resistant 
strains of MTB. Therefore new therapeutic models are needed to overcome this problem. 
During MTB infection, the host antimicrobial response generates several metabolically activated 
DNA alkylating agents leading to severe DNA-damaging injuries on MTB cells. Protection of the 
DNA molecule from chemical damages then strictly depends on the MTB repair mechanisms. 
Recent studies identified an adaptive response mechanism in MTB homologous to that already 
described in E.coli. Being the adaptive response a fundamental biological process for MTB 
viability whereas it is missing in human, this process may represent a putative therapeutic target 
to explore in search for new TB treatments. Previous studies in MTB identified four genes which 
encode the proteins constituent of the adaptive response mechanism homologous to the same 
process already defined in E. coli. Exposure of E. coli to sublethal concentrations of alkylating 
agents induces the expression of four genes (ada, alkA, alkB and aidB). The activation of these 
genes increases the resistance to the cytotoxic and mutagenic effects of alkylating molecules. 
Unlike E. coli, the DNA repair/protection systems in MBT have not been investigated and it is still 
largely unknown. 
This thesis project focuses on the investigation of the adaptive response to DNA methylation 
stress in MTB, in order to identify possible innovative therapeutic targets against tubercular 
infection. 
A non-pathogenic, reference strain of Mycobacteria, M. smegmatis, was used to perform all the 
experiments.  The effect of methylating molecules on M. smegmatis was evaluated using MMS, 
a common laboratory methylating molecule.  
First the effect of alkylating agents was investigated on M. smegmatis cells by evaluating the 
effect of MMS on cell survival, DNA alkylation and on the global proteomic response. 
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Second, structural and functional characterization of the recombinant Ada-Alka and Ogt proteins 
was carried out because of their involvement in the cellular response to alkylating agents.  
Finally, functional proteomic experiments on M.smegmatis Ogt protein was performed in order 
to shine a light on its biological function through the identification of its protein partners in vivo. 
The effect of methylating agents on cell survival was evaluated by monitoring the growth profile 
of bacterial cultures of Mycobacterium smegmatis cells, grown in the presence and in the 
absence of different concentrations of MMS. 
The effect of DNA methylation was quantitatively monitored by Multiple Reaction Monitoring 
tandem MS. N-7-methylguanine (7MeG), O6-methylguanine (7MeG) and N-3-methyladenine 
(3MeA) are the most abundant DNA base modifications by methyl methane sulfonate (MMS). 
Further experiments were then designed in order to investigate the global proteomic response 
of M.smegmatis to methylating stress using bi-dimensional electrophoresis analysis.  
Then, proteomic response to methylation stress was deeply investigated by performing 
quantitative proteomic analyses using the DIGE (Differential In Gel Electrophoresis) technology.  
The identified proteins were functionally classified according to their known biological functions. 
Results obtained in the presence of MMS showed the increasing of proteins involved in biofilm 
formation,  explored by performing specific assays in the presence and in the absence of MMS 
to evaluate the amount of biofilm formed by M.smegmatis. 
In the second part of this thesis project Ada-AlkA and Ogt proteins were produced in E. coli and 
characterised. 
The genes were cloned in pGEX4T1 plasmid vector, producing proteins fused to Glutathione S-
transferase (GST). The recombinant proteins were purified by affinity chromatography on 
immobilized glutathione beads and hydrolyzed in column to release GST. The primary structures 
of recombinant Ada-alkA and Ogt were validated by mass spectrometry methodologies. Circular 
dichroism (CD) analyses highlighted  correctly folded products. The ability of the Ada-alkA and 
Ogt to bind DNA was probed by Elettrophoretic Mobility Shift Asing ssay (EMSA) experiments.  
In the last part, in vivo isolation of Ogt-containing protein complexes was performed using 
functional proteomics approaches in order to shine a light on Ogt biological rol 
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1. Tuberculosis 
1.1 TB epidemiology 
Tuberculosis (TB) is an acute infectious disease that is among the most ancient infection in the 
world.  Signs of disease attributable to tuberculosis were identified in bones of North American 
bovids Pleistocene, demonstrating the presence of the disease in earlier times. This is then 
confirmed by recent studies of DNA sequencing for a bone sample from a bison dated to 17,000 
years before the present .  
Also, the presence of similar pathology in fossil bighorn sheep and musk ox suggests that bovids 
were the likely vehicle for spreading of what became known as the white plague. [1] 
Despite such evidence, the etiology of this disease and the causative agent of TB remained 
unknown until 1882, when the German doctor Robert Koch isolated the bacterial pathogen 
Mycobacterium tuberculosis (MTB), also named Kock bacillus, by  a new staining procedure that 
allowed him to observe the new organism in tuberculous lesions [2].  
In the seventeenth century, in Europe, TB became the leading cause of death, due to the high 
population density, poor sanitation and migration.  
Robert Kock has pioneered the diagnosis and therapy of TB, but although great progress made, 
this disease still represents a global health emergency.  
In 1994-1995, in order to improve TB control programs, the DOTS (Directly Observed Treatment, 
Short-Course) strategy was launched. This strategy was based on five key essential components:  
1) Political commitment with increased finance 
2) Case detection among people presenting with symptoms in clinics through quality-assured 
bacteriology;  
3) Standardized and supervised treatment along with patient support;  
4) Effective drug supply and management system; 
 5) A standard monitoring and evaluation system 
By 2004, more than 20 million patients had been treated in DOTS programmes worldwide and 
more than 16 million of them had been cured. Mortality due to TB has been declining and 
incidence diminishing or stabilizing in all world regions except sub-Saharan Africa and, to some 
extent, eastern Europe [3].  
 
Chapter 1: Introduction 
 
8 
 
According to the World Health Organization (WHO) , in 2012 8.6 million people developed the 
disease, and 1.3 million people died.  Respect to 1990, a 50% reduction in mortality has been 
achieved, but TB incidence is declining too slowly [4-5]. 
 
1.2 Mycobacterium tuberculosis and stage infection 
 The TB causative agent is Mycobacterium tuberculosis, a non sporogenous, aerobic bacterium, 
belonging to the family of Mycobacteria .  
Mycobacteria are intracellular pathogens, characterized by high percentage of guanine and 
cytosine in their genome.  
The main feature of all these micro-organisms is the presence of a complex wall much thicker 
than that in other bacteria, characterized by a high concentration of mycolic acids and fatty 
acids which confers enormous resistance to environmental factors and antibiotic substances (Fig 
1).                                                                           
 
 
Figure 1:  Mycobacterium tuberculosis cell wall 
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Depending on their pathogenicity, these species are divided into Mycobacterium Other Than 
Tuberculosis (MOTT) and Mycobacterium Tuberculosis Complex (MTC), such as Mycobacterium 
africanum (MTB like, isolated in countries of central Africa), Mycobacterium bovis (causative 
agent of bovine TB), Mycobacterium leprae (the causative agent of leprosy) and  Mycobacterium 
tuberculosis (MTB), the causative agent of human TB (fig. 2). 
    
 
Figure 2:  Mycobacterium tuberculosis 
 
MTB has a slow generation time (12-18 hours), due to the complexity of the its cell wall. Its cell 
wall is composed of three covalently linked macromolecules: peptidoglycan, arabinogalctan and 
the hallmark of mycobacteria, myolic acids. Also it possess an important molecule, LAM 
(lipoarabinomannan), representing the virulence factor  [6]. 
In particular, cell wall MTB exterior is primary characterised by the presence of a glycolipid 
molecule, trehalose dimycolate, also known as cord factor. These molecules bring to the 
arrangement of M. tuberculosis cells into long and thin structures named cord factors like the 
glycolipid component. This cellular formation is a key step in pathogenicity of tuberculosis 
infection because can affect immune response and granuloma production [7,8]. 
MTB is transmitted in aerosol droplets coughed out by infected individuals. The infection 
establishes itself in the lungs, where the macrophages start phagocytosis of the bacterium 
generating the primary infection. When the host’s response is efficient, MTB can easily be 
removed, but if the host response is unsatisfactory, the bacterium may survive within  
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macrophages (fig. 3). In this complex enviroment, the mycobacteria are continuously exposed to 
both oxidative and nitrosative stress generated by the activated macrophages that they inhabit. 
When the active phase of infection is over, mycobacteria persist in the infected lung and inhibit 
the fusion of phagosomes and lysosomes causing a chronic infection. Constant antigenic 
stimulation and accumulation of T-cells leads to the formation of a granuloma (fig. 4), which can 
maintain viable bacilli for for a long time. So the infection may enter a stage of latency.  
 
 
 
 
Figure 3: Stages of MTB infection 
 
The structure of a human granuloma is characterized by a central region of large CD68+ 
epitheloid cells, surrounded by macrophages, T-lymphocytes (predominantly CD4+) and multi-
nucleate giant Langerhans cells. [9] 
The central region of the granuloma does not contain blood vessels and becomes hypoxic [10]. 
When the granuloma becomes necrotic, it may either be resolved by fibrosis and calcification or 
become liquefied, therefore leading to dissemination of any pathogens contained within it. 
 The state of latency can be very long until the breakage of the granuloma generates the reactivation 
of the disease. This phenomenon occurs for two main reasons: one of the causes is the essential  
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formation failure and the co-location signals maintenance from macrophages and T-cells, even if 
there are other events that suggest that T-cells remain effective. The other one is related to a 
decline in the host's immunity, which may derive from the host genetic susceptibility or from 
environmental reasons, such as co-infection with HIV. 
 
Figure 4: Granuloma formation 
 Current therapeutic treatments of TB disease consist in the use of multiple anti-mycobacterial 
drugs such as Rifampicine and Isoniazid. Both latent TB infection and TB disease can be treated 
with just one drug or more in combination [11]. Rifampicine seems to have a discreet success on 
both metabolic conditions. Isoniazid and Streptomycin are effective on metabolic active bacteria 
and Ethambutol, an Isoniazid  derivative, has a bacteriostatic action. The results of such therapies 
are not very satisfactory: the treatment requires many months of administration and the 
Chapter 1: Introduction 
 
12 
 
combination of multiple drugs can create a certain amount of side effects [12]. 
Particularly, the  latent phase of TB is characterized by the absence of clinical signs and 
individuals with such latent TB are non-infectious [13]. In this phase there is a reduced response 
to antibiotic therapy and moreover it was found that HIV co-infection lead to a greater than 100-
fold risk of developing active tuberculosis [14]. 
The term dormancy is used to refer to the state in which bacteria are found during clinical 
latency: they appear to remain viable, do not divide, but they are surely able to reactivate and 
resume cell division [15]. 
 
2. DNA damage 
 
Because of its permanence in a hypoxic environment and exposure to selective antibiotics, 
during latency the bacterium undergoes DNA damage that result in the occurrence of drug-
resistant, multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. 
An interesting approach to understanding the emergence of drug-resistant strains is the study of 
mutation rates of the bacterium. 
It has been proved that the mutation rate of animal extracted Mycobacteria with active, latent 
and reactivated infection is quite similar in the three phases of the disease. MTB keeps acquiring 
mutations during latency [16]. The identified polymorphisms pattern suggest that the amount in 
vivo mutations derives from the DNA oxidative damage. 
Thanks to the whole bacterium genome sequencing the mutation rate has been quantified and 
14 single nucleotide polymorphisms (SNPs) have been identified. The mutation rate (µ) of a 
bacterium,  in vivo, can be derived from the number of mutations (m) in a genome of known size 
(N) in time (T). 
 
 
  Mutation rate μ 
Latent infection 
2,71 x 10 
-10 
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Reactivated infection 
3,03 x 10 
-10 
Active infection  
2,01 x 10 
-10 
   
Bacteria populations have the same number of mutations in time, independently of the number 
of bacterial replications. So, the polymorphisms identified are probably caused by an oxidative 
damage [17].  
Therefore new therapeutic models are needed, to reduce treatment duration, decrease dosing 
frequency, improve the treatment of MDR and XDR,  in order  to overcome this problem [18]. 
Reactive species such as free radicals, one-electron oxidants, different chemicals, etc., can react 
with different components of DNA to produce a plethora of DNA lesions. 
During the infection, MTB is exposed  to a multitude of hostile conditions, due to host defense 
systems and antibiotic treatments. Particularly MTB undergoes a variety of potentially DNA-
damaging assaults, primarily from host-generated antimicrobial reactive oxygen intermediates 
(ROI) and reactive nitrogen-intermediates (RNI) [19] . 
Microorganisms evolved in a world lacking of oxygen and rich with reduced iron. The 
subsequent oxygenation of the atmosphere by photosynthetic organisms created a crisis: 
oxygen is a reactive chemical, and organisms had to devise strategies to defend themselves. 
Molecular oxygen is small and non-polar, and it quickly diffuses across biological membranes 
and water. Consequently, cells cannot respire quickly enough to lower the intracellular oxygen 
concentration substantially below the concentration immediately outside the cell. Some 
microorganisms escape oxidative stress by residing in anaerobic micro habitats; all others must 
contend with intracellular molecular oxygen. 
However, virtually all of these microorganisms suffer poor growth, elevated mutagenesis or 
even death when they are exposed to oxygen levels that exceed those of their native habitats. 
The oxygen toxicity derives mostly from the formation of partially reduced oxygen species 
(ROS)[20]. The hydroxyl radical  is a highly reactive oxygen species (ROS) that efficiently reacts 
with nearby biomolecules at diffusion-controlled rates of reaction. The reaction volume of 
radicals is less than 2 nm in cells and tissues; thus, it reacts essentially at the site of generation. 
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The most likely source of OH in cells is the Fenton reaction, which involves the reaction of 
reduced redox active metal ions, such as ferrous and cuprous ions, with metabolically produced 
H2O2 [21]. The oxidative damage greatly contributes to  spontaneous mutation in bacterial cells 
[22]. 
Nitric oxide is a key participant in many physiological pathways; however, its reactivity gives it 
the potential to cause considerable damage to cells and tissues in its vicinity.  
Formation of nitric oxide (NO˙) catalysed by nitric oxide synthase can produce ONOO− due to its 
reaction with O2˙-, which is very reactive. More interestingly, ONOO− itself is capable of 
generating other reactive species that are very reactive. For example, the conjugate acid of 
ONOO−, i.e. ONOOH on homolytic dissociation, can generate reactive  O2 and OH radicals. 
Furthermore, in the presence of carbon dioxide (CO2), ONOO− can generate 
nitrosoperoxycarbonate anion (ONOOCO2−), which on homolytic dissociation may yield CO3˙− 
and NO2˙ free radicals [23]. 
Nitric oxide can react with DNA via multiple pathways. Once produced, subsequent conversion 
of nitric oxide to nitrous anhydride and/or peroxynitrite can lead to the nitrosative deamination 
of DNA bases such as guanine and cytosine. Complex oxidation chemistry can also occur 
causing oxidative modifications on DNA bases and sugars [24]. 
The cytotoxic and mutagenic effect of ROIs and RNIs is based on a number of chemical reactions 
that modify DNA, including several metabolically activated DNA alkylating agents [23,25]. 
Specifically, alkylating agents are molecules having one or more alkyl groups able to react with 
nucleophilic sites on DNA bases causing covalent modifications known as adducts [26]. The most 
reactive sites to be attacked by alkylating molecules are the ring nitrogens (N) and the 
extracyclic oxygen (O) atoms of DNA bases. 
The chemical lesions pattern depends on the kind of alkyl agents and on their features, such as 
the number of reactive sites, the type of group added (methyl, chloroethyl, etc.) and its 
reactivity (type of nucleophilic substitution) [27].  
 If alkylating agents contain one active chemical moiety, it can modify DNA in a single site while 
bifunctional species possessing two reactive groups can bind simultaneously two sites 
generating intra- or inter-strand crosslinks. 
DNA alkylation on reactive groups can occur by both SN2 mechanism by targeting ring nitrogen 
atoms and SN1 mechanism modifying nitrogen and extra cyclic oxygen groups (fig 5). 
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Amongst alkylating species, monofunctional methylating agents induce preferentially the 
formation of N-7-methylguanine (7MeG) at a rate of 60-80% of the total alkylation lesions 
because of the high nucleophilic reactivity of the N7 position of guanine. Mono-methylating 
agents can also produce N-3-methyladenine (3MeA) with an amount of 10-20% of total methyl 
adducts. In addition oxygen at position 6 of guanine is the most reactive oxygen in DNA and it is 
modified by SN1 alkylating agent to form O6-methylguanine (O6MeG). 
 
 
    
Figure 5:   Schematic mechanism of DNA alkylation through nucleophilic substitutions: B is the       
nucleophilic base while the leaving group is donated by the alkylating agent. 
 
 
 
 
 
 
 
2.1 DNA repair 
 
Living cells are evolved with intelligent enzymes that protect DNA from erroneous and 
hazardous effects by executing about 1016–1018 repair events per cell per day [28]. 
Because of the technical difficulties in working with a slow-growing pathogen such as M. 
tuberculosis, the study of DNA repair systems in this organism has advanced more slowly than 
for other bacteria.  
 Base excision repair (BER), Nucleotide excision repair (NER), recombination and SOS repair 
system genes were identified in the MTB genome [29]. 
BER ( base excision repair) is one of the most important DNA repair systems in nature. It can 
protects the bacterial genome  from damage and harmful mutations, therefore it is essential for 
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the bacterium survival (fig. 6) [19]. The process to DNA repair starts off with the activation of 
DNA glycosylases that produces in DNA an AP-site ( a location  in DNA that has neither a purine 
nor a pyrimidine base). These sites occur as intermediates in base excision repair, but they can be 
also caused by spontaneous depurination . In this process, the DNA glycosylase recognizes a 
damaged base and cleaves the N-glycosidic bond to release the base. This event is followed by 
strand cleavage of the sugar-phosphate backbone by an AP-endonuclease, leaving 3' hydroxyl 
and 5' deoxyribosephosphate termini.  
The process is completed by the actions of phosphonucleotide kinase or a 3’- or 
5’deoxyribosephosphodiesterase. Later a DNA polymerase fill in a new base and a DNA ligase 
seals the gap. M. tuberculosis possesses two redundant DNA polymerases involved in 
replication: DnaE1 and DnaE2. DNA polymerase DnaE1 is a replicative polymerase whereas DNA 
polymerase DNAE2 is upregulated by UV-induced DNA damage. In Mycobacterium tuberculosis 
this pathway is induced when the bacterium is exposed to oxidative stress such as hydrogen 
peroxide (H202), superoxide and hydroxyl radicals from exogenous and endogenous sources.  
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Figure 6: BER system 
NER (nucleotide excision repair) is an alternative pathway to BER that acts on oligonucleotide 
excision (fig. 7). This system uses an endonucleases with low specificity therefore it is  able to 
recognize a more broad range of damaged bases than the BER system. The NER pathway is 
composed by three components of the excinuclease ABC (UvrA,UvrB and UvrC), the DNA 
helicase II UvrD and the transcription repair-coupling factor (TRCF). According to studies, uvr 
gene expression is increased in M. tuberculosis isolated from human macrophages, 
demonstrating the importance of the uvr system for the bacterial survival upon infection [30]. 
In addition recent studies have demonstrated that uvr genes are involved in the response to 
H202 [31] and they are upregulated upon exposure to UV irradiation [32]. Furthermore, while 
most bacteria possess just one gene encoding DNA helicase II, M. tuberculosis has two putative 
gene encoding this protein: uvrD1 and uvrD2 [33]. The protein UvrD1 seems to be important to                                                             
rapair DNA by UV damage and is upregulated by H202-induced stress  whereas the protein 
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UvrD2 is essential for the survival of mycobacteria [34] NER is a complex process in which 
basically the following steps can be distinguished:  
 recognition of a DNA lesion;  
  separation of the double helix at the DNA lesion site;  
  single strand incision at both sides of the lesion;  
 excision of the lesion-containing single stranded DNA fragment;  
 DNA repair synthesis to replace the gap  
  ligation of the remaining single stranded nick.  
 
Figure 7: NER system 
  Breakage of the both strands of double helix (DSB) is another type of lethal damage to DNA 
forthe cells during replication or following exposure to DNA-damaging agents. There are two 
major DSB repair pathways: homologous recombination (HR) and nonhomologous end-joining 
(NHEJ) (fig. 8). HR is an homologous recombination where the second intact copy of the broken 
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chromosomal segment functions as a template for DNA synthesis across the break [35]. In this 
pathway, an 5’-exonuclease hydrolyzes the DNA after the break, generating sticky ends. Later 
the RecA protein promotes strand exchange and the resulting joint molecules can be processed 
by the RuvABC complex or RecG helicase. There are two major RecA-dependent pathway in 
initiating HR: the RecBCD and RecFOR pathway. RecBCD pathway is a bipolar helicase that 
separate the duplex into its component strands and digest them until it reaches a 
recombinational hotspot [36] whereas RecFOR pathway is important in postreplication 
daughter-strand gap repair [37].  According to studies, RuvA and RuvC, belonging to RuvABC 
complex, are upregulated upon UV damage in M. tuberculosis [32]. 
NHRJ joins together two ends of DNA after the break in the absence of a sequence or a 
chromosomal copy that can serve as a mold. The process starts off with the action of DNA-end-
binding protein Ku, followed by the sealing of the broken strands by a specialized DNA ligase 
LigD [38]. LigD is a multifunctional enzyme formed by an ATP-dependent ligase (LIG) domain, a 
polymerase (POL) domain and a phosphoesterase (PE) domain. According to studies, NHEJ 
system is not conserved in all bacterial species but in mycobacterium it may be important during 
the latent phase of human tuberculosis. In fact this mechanism is resulted necessary for the 
mycobacterial survival during latent phase or reactivation from latency because when 
mycobacteria stay within microphages, they are continually exposed to the genotoxic defense 
mechanism of the host cell as the oxidative stress. Also this systems promotes mutagenesis so it 
results to be important for this mycobacterium to accumulate potential selective advantage 
under certain condition such as the acquisition of antibiotic resistance [35]. 
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Fig.8 : Homologous recombination (a) and nonhomologous end-joining (b 
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2.2 Adaptive  response 
Among the repair mechanisms of DNA alkylation damage, some bacterial species have 
developed  an adaptive response to alkylation stress [39] that is widely described in E.coli.  
When E. coli is exposed to sublethal doses of alkylating agents  it increases the cellular 
resistance to the mutagenic and cytotoxic effects of alkylation with increasing doses of 
damaging molecules. 
The adaptive response set of genes is comprised of the ada, alkA, alkB, and aidB genes. 
Expression of these genes is regulated by Ada, (fig 9)  that is a methyltransferase that also acts 
as positive regulator of the operon. 
 
  
 
 
Figure 9 : Ada dependent mechanism 
  
 It has two cysteine residues, Cys-69 and Cys-321 that act as active methyl acceptor [40]: the 
first one is required to demethylate phosphomethyltriesters in the sugar phosphate backbone 
and the second one to remove methyl groups from either O6-methylguanine or O4-
methylthymine. Both sites can be methylated from the specific substrates but only methylation 
by phosphates causes Ada conformational changes that induce the transcriptional regulator 
activity of the protein. Even though methylated phosphates are less dangerous than other 
lesions, these sites are the most quickly modified by  methylating agents and thereby represent 
a sensitive regulatory signal leading to Ada operon induction.  [41]. 
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AlkA protein is a glycosylase that repair several damages such as N7-methylguanine and N3-
methyl purines and O2-methyl pyrimidines. The mechanism of action comprises the removal of 
a damaged base from the sugar phosphate backbone through cleavage of the glycosylic bond 
leading to an abasic site. 
AlkB protein is an oxidative demethylase capable of removing 1-methyladenine and 3-
methylcytosine from DNA using an α ketoglutarate/Fe(II)-dependent mechanism coupled with 
the release of CO2, succinate and formaldehyde [42]. 
Aidb is an  Acyl-CoA dehydrogenase prevents DNA damage by alkylating agents and counteracts 
the block to transcription resulting from exposure to alkylating agents, preferentially acting on 
genes that are transcribed from promoters containing upstream (UP) elements [43]. 
Recent studies identified an adaptive response mechanism in MTB homologous to that already 
described in E.coli.  
Due to bacterial evolution the genomic organization of the adaptive response is differently 
composed in E. coli and MTB ( Fig 10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Schematic organization of chromosomal organization of the adaptive response genes 
in E. coli and MTB. 
M.tuberculosis E. coli 
 
  adaA   ada B 
 
alkB 
 
   alkA 
 
          aidB 
ogt 
  
      ada-alkA 
 
   alkB 
 
          fadE8 
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In MTB N-terminal domain of Ada (Ada A) is fused with AlkA and C-terminal domain (AdaB) 
constitutes a separate protein annotated as ogt. In both AdaA-AlkA and Ogt there are critics 
residues conserved. 
The most interesting features includes the zinc finger of AdaA, the active site thiol of AdaA 
(Cys38 in E. coli, Cys34 in M. tuberculosis) and AdaB (Cys321 in E. coli, Cys126 in M. tuberculosis), 
the helix-hairpin-helix motifs (HhH) of AdaB and AlkA, the arginine finger of AdaB as well as the 
catalytic aspartic acid (Asp238 in E. coli, Asp441 in M. tuberculosis) of AlkA. 
Exposure of MTB to a methylating molecule strongly increases transcription of adaA-alkA and 
Ogt, demonstrating an inducible response to methylating agents.  
Based on homology the AdaA-AlkA protein is predicted to transfer methyl groups from 
methylphospotriesters of the DNA backbone to a conserved cysteine residue (Cys34) of the 
AdaA domain, suggesting that AdaA-AlkA is converted to a positive transcriptional regulator of 
the adaptive response to DNA alkylation damage in M. tuberculosis [44] while recent studies 
demonstrated that Ogt acts through a suicidal mechanism, by performing the stoichiometric 
transfer of the O6-alkyl group from the modified guanine to a strictly conserved cysteine residue 
(Cys 126) in the protein active site, which is hosted in the C-terminal domain of the protein (fig. 
11). This covalent modification leaves OGT permanently inactivated and possibly more prone to 
degradation [45]. 
 
 
Figure 11: Ogt structure 
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The investigation of the DNA repair and protection mechanisms is really interesting in the 
tuberculosis context because of their involvement in the drug resistant development. Moreover, 
proteins involved in these mechanisms represent excellent therapeutic targets because of the 
fundamental role they play in bacterial survival and due to the absence of homologues in 
humans [46]. 
 
 
3. Aims 
 
Tuberculosis (TB) is an infectious disease caused by the micro-organism Mycobacterium 
tuberculosis (MTB) that currently represents a global health emergency with around 9 million 
people affected and nearly 2 million deaths each year. Current therapeutic treatment for TB 
consists in the use of multiple anti-mycobacterial drugs such as rifampicin and isoniazid. This 
treatment is carried out for a long time leading to the onset of drug- and multidrug-resistant 
strains of MTB. Therefore new therapeutic models are needed to overcome this problem. 
During MTB infection, the host antimicrobial response generates several metabolically activated 
DNA alkylating agents leading to severe DNA-damaging injuries on MTB cells. Protection of the 
DNA molecule from chemical damages then strictly depends on the MTB repair mechanisms. 
Recent studies identified an adaptive response mechanism in MTB homologous to that already 
described in E.coli. Being the adaptive response a fundamental biological process for MTB 
viability whereas it is missing in human, this process may represent a putative therapeutic target 
to explore in search for new TB treatments. Previous studies in MTB identified four genes which 
encode the proteins constituent of the adaptive response mechanism homologous to the same 
process already defined in E. coli. Exposure of E. coli to sublethal concentrations of alkylating 
agents induces the expression of four genes (ada, alkA, alkB and aidB). The activation of these 
genes increases the resistance to the cytotoxic and mutagenic effects of alkylating molecules. 
Unlike E. coli, the DNA repair/protection systems in MBT have not been investigated and it is still 
largely unknown. 
This thesis project focuses on the investigation of the adaptive response to DNA methylation 
stress in MTB. 
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In the first part of this project the effect of methylating agents on Mycobacterium smegmatis 
cells was investigated. It was evaluated on cell survival by monitoring the growth profile of 
bacterial cultures grown in the presence and in the absence of different concentrations of 
methylmethansulfonate (MMS),a common laboratory methylating molecule.  The effect of DNA 
methylation was also quantitatively monitored by Multiple Reaction Monitoring tandem MS.  
Then, the global proteomic response of M.smegmatis to methylation stress was investigated by 
performing a quantitative proteomic analyses in order to identify and functional analyze the 
differentially expressed proteins in the presence and in the absence of the methylating 
molecule. 
The second purpose of this thesis is to characterize the proteins of the  adaptive response in 
MTB. 
Ada-AlkA and Ogt proteins were  structurally and functionally characterized because of their key 
role in the cellular response to alkylating agents. 
Lastly, functional proteomic experiments on M.smegmatis Ogt protein was performed in 
orderto shine a light on its biological function through the identification of its protein partners in 
vivo.
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1. M. smegmatis growths 
Mycobacterium smegmatis is an acid-fast bacterial species in the phylum Actinobacteria and the 
genus Mycobacterium. It is useful for the research analysis of other Mycobacteria species in 
laboratory experiments because of its being a "fast grower" and non-pathogenic. M. smegmatis 
is a simple model that requires only a biosafety level 1 laboratory. For these reasons, M. 
smegmatis is usually used as a model for mycobacterial species. 
Wild type cells were grown 3 days in LB medium at 37 °C and they were diluted 1:100 in fresh 
medium containing 100μg/mL ampicillin, 0.05% tween 80. At an A600 nm of 0.4, the cultures 
were divided in aliquots and one of these was manteined as the untreated control while the 
others were supplemented with MMS in a 0.01-0.1% w/v range. Growing profiles were obtained 
by monitoring cells for 35 hours. 
 
2. Genomic DNA extraction 
Cellular pellets were treated as described by Telenti and co-workers to extract genomic DNA 
(Rapid identification of mycobacteria to the species level by polymerase chain reaction and 
restriction enzyme analysis. A Telenti, F Marchesi, M Balz, F Bally, E C Böttger, and T Bodmer). 
 
3. LC-MS/MS analyses of methylated bases 
The DNA samples were subjected to acidic hydrolysis in 0.1 M HCl at 80 °C for 30 min to obtain 
free bases. The samples were dried under vacuum and solubilized in 50 μL of 3% (v/v) methanol 
(MeOH)/0.1% (v/v) trifluoroacetic acid for methylated purine analysis. Standard methylated 
bases (Sigma-Aldrich) were solubilized in 3% (v/v) methanol (MeOH)/0.1% (v/v) trifluoroacetic 
acid [39]. Samples were then analyzed by reverse-phase HPLC associated with an Agilent Triple 
quadrupole 6420 used in the multiple reaction monitoring mode. The C18 column was eluted 
with a flow rate of 0.2ml/min starting with 3% (v/v) MeOH/0.1% (v/v) formic acid. The column 
was delivered at 3% MeOH for 2 minutes. The percentage of MeOH reached 75% in 5 min and 
rapidly back to 3% MeOH.  
The amount of methylated bases was obtained by external calibration in the range of 10-80 pg.  
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4. Bi-dimensional analyses of M.smegmatis cells 
2D electrophoresis IEF (first dimension) was carried out on nonlinear wide-range immobilized 
pH gradients (pH 3-10; 18 cm long IPG strips; GE Healthcare, Uppsala, Sweden) and achieved 
using the Ettan IPGphor system (GE Healthcare, Uppsala, Sweden). Analytical-run IPGstrips were 
for 1h at 0 V and for 8h at 30 V, at 16°C. The strips were then focused according to the following 
electrical conditions at 16°C: 200 V for 1h, from 300 V to 3500 V in 30 min, 3500 V for 3h, from 
3500 V to 8000 V in 30 min, 8000 V until a total of 80000 Vh was reached. For preparative gels 
400μg of total proteins were used. After focusing, analytical and preparative IPG strips were 
equilibrated for 12 min in 6 M urea, 30% (V/V) glycerol, 2% (w/V) SDS, 0.05 M Tris-HCl, pH 6.8, 
2% (w/V) DTE, and subsequently for 5 min in the same urea/SDS/Tris buffer solution but 
substituting the 2% (w/V) DTE with 2.5% (w/V) iodoacetamide. The second dimension was 
carried out on 10% polyacrylamide linear gradient gels at 40 mA/gel constant current until the 
dye front reached the bottom of the gel, according to Laemmli et al and Hochstrasser et al. Gels 
were stained with colloidal coomassie.  
 
4.1 In situ digestion 
Protein bands in 1D gels were reduced by incubation with 50 µL of 10 mM DTT in 0.1 M 
ammonium bicarbonate buffer (pH 7.5) and alkylated with 50 µL of 55 mM iodoacetamide in the 
same buffer. Enzymatic digestion was carried out with trypsin (12.5ng/μl) in 50mM ammonium 
bicarbonate pH 8.5 at 4°C for 4 hours. The buffer solution was then removed and a new aliquot 
of the enzyme/buffer solution was added for 18 hours at 37°C. A minimum reaction volume, 
enough for the complete rehydratation of the gel was used. Peptides were then extracted 
washing the gel particles with 20mM ammonium bicarbonate and 0.1% TFA in 50% ACN at room 
temperature and then lyophilized.  
Spots of interest in 2D gels were excised, washed first with ACN, then with 0.1M ammonium 
bicarbonate and enzymatic hydrolysed by trypsin as just described. 
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4.2 LC-MS/MS Analyses 
  
 Tryptic peptide mixtures obtained from in situ digestions were analysed by LC/MS/MS 
using an HPLC-Chip/Q-TOF 6520 (Agilent Technologies). The peptide mixtures were injected by 
auto sampler. They were sent to the enrichment column of the chip at flow rate of 4 μL/min, in 
98% water, 2% acetonitrile and 0.1% formic acid. Subsequently the peptides were eluted 
directly into the capillary column (C18 reversed phase), at a flow rate of 0.4 μL/min. The 
chromatographic separation was carried out with a linear gradient in 95% acetonitrile, 5% water 
and 0.1% formic acid. The eluate was then introduced in the ESI source for the tandem analysis. 
In this way each mass spectrum (range 300-2,400 m/z) was followed by one or more tandem 
mass spectra (range 100-2,000 m/z), obtained by fragmenting the most intense ions in each 
fraction eluted chromatographic. The acquired MS/MS spectra were transformed in Mascot 
generic file format and used for peptides identification with a licensed version of MASCOT 
(modular approach to software construction, operation and test, matrix science, USA), in a local 
database. 
 
 
5. DIGE tecniques  
DIGE experiments were performed on four biological replicates of MMS treated and four 
biological replicates of MMS untreated M.smegmatis as previously described [12]. Cells were 
homogenized in 0.5 ml of lysis buffer (7M urea, 2M thiourea, 4% chaps, 30mM Tris-HCl pH 7.5) 
using a Dounce homogenizer. The protein extract concentrations were determined and equal 
amounts of the protein lysates were then labeled in vitro using two different fluorescent 
cyanine minimal dyes (Cy3 and Cy5, respectively) differing in their excitation and emission 
wavelengths. A third cyanine dye (Cy2) was used to label a mixture of all samples as internal 
standard. The three differently labeled protein mixtures were pooled and subjected to 
isoelectric focusing through a pH range of 3-10 over a length of 24 cm. The reducing and 
alkylating steps were performed between the first and the second electrophoretic step. 
Acrylamide strips were then transferred to the top of a classical SDS PAGE gel for a second 
orthogonal electrophoresis analysis. The Cy2, Cy3 and Cy5 images were obtained by scanning  
 
Chapter 2: Experimental section 
32 
 
each of the four DIGE gels at excitation/emission wavelength of 480/ 530 nm for Cy2, 520/590 
nm for Cy3 and 620/680 nm for Cy5 using a Typhoon 9410 TM scanner (GE Healthcare). The 
semi-preparative gel, prepared in an identical fashion, was scanned with 480/633 nm 
wavelengths. After consecutive excitation at both wavelengths, the images from the preparative 
gel were overlaid and subtracted (normalized) from the samples, whereby only differences (up 
or down regulated proteins) between the two samples were visualized. By performing a high 
resolution image analysis on the six biological replicates, it was possible to visualize significant 
differences between numerous protein spots present on the gels. Differentially regulated spots 
were defined as having a variation higher than 1.2 (p<0.05) per previously established methods 
[13].The gels showed a high degree of similarity, with more than 80% of all spots 
superimposable. The remaining 20% showed variation and were further studied.  
 
5.1 Proteomic analysis  
The spots of interest were excised, hydrolyzed and the peptide mixtures analyzed by MALDI-MS 
and LC-MSMS mass spectrometry, on a 4800 Plus MALDI TOF/TOF™ (Applied Biosystems, 
Framingham, MA, USA) and a LC/MSD Trap XCT Ultra (Agilent Technologies, Palo Alto, CA) 
equipped with a 1100 HPLC system and a chip cube (Agilent Technologies) respectively. MALDI 
spectra were acquired in the positive ion reflector mode using delayed extraction in the 800 - 
4000 Da mass range. LC-MS/MS analysis was performed using data-dependent acquisition of 
one MS scan followed by MS/MS scans of the three most abundant ions in each MS scan. Raw 
data analyses were converted into a Mascot format text to identify proteins using Matrix 
Science software. The protein search considered the following parameters: non-redundant 
protein sequence database (NCBInr), specificity of the proteolytic enzyme used for the 
hydrolysis (trypsin), taxonomic category of the sample, no protein molecular weight was 
considered, up to one missed cleavage, cysteines as S-carbamidomethylcysteines, unmodified N- 
and C-terminal ends, methionines both unmodified and oxidized, putative pyro-Glu formation 
by Gln, precursor peptide maximum mass tolerance of 200 ppm, and a maximum fragment mass 
tolerance of 200 ppm. 
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5.2 Bioinformatic analysis of identified proteins 
Identified proteins were used to determine predicted interactions with other proteins. This 
functional protein association network for the each entry was obtained by searching the STRING 
online database (http://string-db.org). Proteins were analyzed with the STRING software. 
 
 
6. Static biofilm assay 
The wells of a sterile 96-well flat-bottomed polystyrene plate (Falcon) were filled with 90 mL of 
the appropriate medium containing or not containing the inhibitors. 10 mL of overnight 
bacterial cultures grown in LB was added into each well. The plates were incubated aerobically 
with or without the enzyme for 24 h at 37 °C in the presence of either 0.03% MMS. Growth was 
monitored by measuring the OD600, and after 24 h incubation the ability of the M.smegmatis 
strain to adhere to the polystyrene plates was tested. The content of the plates was then 
poured off and the wells washed with sterile distilled water. The plates were then stained with 
crystal violet for 5 min. Excess stain was rinsed off by placing the plate under running tap water. 
After the plates were air dried, the dye bound to the adherent cells was solubilized with 20% 
(v/v) glacial acetic acid and 80% (v/v) ethanol per well. The OD of each well was measured at 
590 nm.  
 
7. Construction of expression vectors 
The ogt and ada-alkA genes of M. tuberculosis were amplified from genomic DNA by PCR. ogt 
amplification product was directly ligated with a pGEM Teasy vector. Then to obtain protein 
tagged with GST protein, the pGEM Teasy-ogt construct was digested with SmaI and BamHI and 
cloned into the pGEX4T1 vector. ada-alkA amplification product was directly hydrolysed with 
BamHI and XhoI and cloned into the pGEX4T1 vector. Plasmids construction was verified by 
automated DNA sequencing.  
 
7.1 Plasmidic vectors 
The pGEM®-T Easy Vectors is a linearized vector with a single 3´-terminal thymidine at both 
ends. The T-overhangs at the insertion site greatly improve the efficiency of ligation of PCR  
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products by preventing recircularization of the vector and providing a compatible overhang for 
PCR products generated by certain thermostable polymerases. The pGEM®-T Easy Vector is a 
high-copy-number vectors containing T7 and SP6 RNA polymerase promoters flanking a multiple 
cloning region within the α-peptide coding region of the enzyme β-galactosidase. Insertional 
inactivation of the α-peptide allows identification of recombinants by blue/white screening on 
indicator plates. 
 
 
Figure A : pGEM®-T Easy Vector Map 
 
The pGEX-4T-1 vector contains a tac promoter for chemically inducible, high-level expression of 
Glutathione S Transferase tagged recombinant protein. Moreover this vector permits to obtain 
Thrombin recognition site for cleaving the desired protein from the fusion product.  
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Figure B: pGEX-4T-1 vector map 
 
8. Production and Purification of Recombinant Proteins 
BL21 and C41 E.coli recombinant cells were grown at 37 °C to an OD (optical density) at 600 nm 
of about 0.5, at which time 0.1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) was added in 
order to express ogt and ada-alkA genes. Selective antibiotic was used at concentration of 100 
µg/mL ampicillin. Cells were grown at 20°C for 16 hours to obtain recombinant expression of 
ogt. After incubation, cells were harvested by centrifugation at centrifugal force of 5,000 x g for 
15 min at 4 °C, resuspended in Na2PO4 50mM, NaCl 150 mM, 1 mM PMSF pH = 7.4 and 
disrupted by passage through a French press and centrifuged at centrifugal force of 14000 rpm 
for 15 min at 4 °C. Recombinant proteins were purified by affinity chromatography on 
Glutathione-Agarose beads (Sigma). After 2 hours of incubation at 4 °C, the matrix was collected 
by centrifugation at centrifugal force of 11000 rpm for 1 min and washed three times with 
Na2PO4 50mM, NaCl 150 mM and Triton 1%. The recombinant proteins were eluted with Tris –  
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HCl buffer pH = 8 containing reduced glutathione 1 mM. Protein concentration was estimated 
with Bradford reagent (Bio-Rad protein assay) and protein content was checked by SDS-PAGE. 
 
 
9. Circular Dichroism analyses 
Proteins were equilibrated in 20 mM sodium phosphate buffer pH 7.4 and analysed. Circular 
dichroism (CD) measurements were recorded at 25 °C, using a J-750 spectropolarimeter 
equipped with a Peltier type temperature control system (Model PTC-348WI). Cells of 0.1 cm 
path length were used in all measurements.  
 
10. Electrophoretic mobility shift assay 
DNA probe of 28 bp having random sequence was used. Sense and antisense oligonucleotides 
were annealed by incubation at 95 °C for 5 min and successive gradual cooling to room 
temperature. Purified recombinant Ogt or Ada-AlkA were incubated with the probes for 20 min 
at room temperature in 20 µl of buffer Z (25 mM HEPES pH 7.6, 50 mM KCl, 12.5 mM MgCl2, 1 
mM DTT, 20% glycerol, 0.1% triton). Protein–DNA complexes were separated on 1.5% agarose 
gel, containing Gel Red Dye 1x, in 0.5 × TBE (45 mM Tris pH 8.0, 45 mM boric acid, 1 mM EDTA) 
at 80 V at room temperature. Visualization of DNA samples was carried out by using UV 
radiation.  
 
 
11. Pull down experiment 
E.coli cells overproducing GST-Ogt were grown at 37 °C to an OD at 600 nm of about 0.5, at 
which time 0.1 mM isopropyl-beta-D-thiogalactopyranoside (IPTG) was added in order to 
express the gene. Cells were grown at 20°C for 16 hours to obtain recombinant expression of 
ogt. After incubation, cells were harvested by centrifugation at centrifugal force of 5,000 x g for 
15 min at 4 °C, resuspended in Na2PO4 50mM, NaCl 150 mM, 1 mM PMSF pH = 7.4 and 
disrupted by passage through a French press and centrifuged at centrifugal force of 14,000 x g 
for 15 min at 4 °C. Recombinant proteins were immobilized by affinity chromatography on 
Glutathione-Agarose beads as the bait of pull down experiment. Simultaneously M.smegmatis 
wild type cells were grown in LB medium containing 100μg/mL ampicillin, 0.05% tween 80. At an  
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A600 nm of 0.4, the cultures were divided in two aliquots and one of these was maintained as 
the untreated control while the other was supplemented with 0.03% MMS. After 3 hours cells 
were recovered by centrifugation at 4000 rpm at 4°C for 15 minutes. Cells were disrupted 
Na2PO4 50mM, NaCl 150 mM, 1 mM PMSF pH = 7.4 by passage through a French press and 
centrifuged at 14000 rpm for 30 min at 4 °C. Cellular extracts from both samples were subjected 
to a pre-cleaning step by incubation with Glutathione-Agarose beads in order to isolate non 
specific binding proteins. Then treated and untreated M.smegmatis extracts were incubated 
with Glutathione-Agarose immobilized GST-Ogt protein to allow protein complexes formation. 
After 16 hours of incubation both the pre-cleaning and affinity chromatography resins were 
recovered and washed with Na2PO4 50mM, NaCl 150 mM and Triton 1%.  
Ogt protein complexes were eluted with Tris – HCl buffer pH = 8 containing reduced glutathione 
1 mM. Protein concentration was estimated with Bradford reagent and protein content was 
checked by SDS-PAGE and western blot analyses. 
 
 
12. Western blot analyses 
Protein complexes were resolved by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) under reducing conditions using standard procedures (Sambrook & 
Russell, 2001). The proteins were transferred on to a polyvinylidene difluoride (PVDF) 
membrane using an electroblotting transfer apparatus (Trans-Blot Semi-Dry Transfer Cell, Bio-
Rad). GST tagged proteins were detected using the anti-GST mouse monoclonal antibody and 
peroxidase-conjugated anti-mouse secondary antisera. The membrane was developed using 
SuperSignal West Femto Maximum Sensitivity Substrate detection kit (Pierce) according to the 
manufacturer’sinstructions. 
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1. Effect of methylating agent on Mycobacterium smegmatis growth 
 
The effect of methylating molecules on M. smegmatis cells was investigated in order to evaluate 
whether limited doses of methylating agent might affect M. smegmatis cell growth. Methyl 
methansulfonate (MMS) was used as methylating molecule. 
To evaluate the lowest amount of reagent clearly affecting cells growth, M. smegmatis cells 
were grown in the presence and in the absence of different concentrations of MMS in a 0.01-0.1 
% w/v range and the viability of bacterial cultures was monitored for 24 hours. Figure 12 clearly 
shows a decrease in cell survival with increasing doses of MMS in comparison with untreated 
cells (CN). 
 
 
 
 
 
 
 
Figure 12: Growth profile of M. smegmatis cells in the presence and in the absence of several 
concentrations of MMS 
 
These data demonstrated that 0.03% MMS concentration led to a decrease of about 50% in cell 
survival, indicating that in these conditions M. smegmatis cultures were affected by alkylation.  
This concentration was then selected for further experiments.  
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2. Quantitative analyses of DNA methylation in M. smegmatis cells 
 
In order to examine the effect of methylation stress on DNA molecule, DNA methylation was 
quantitatively assessed by LC-MS/MS analysis in Multiple Reaction Monitoring mode, in the 
presence and in the absence of methylation stress [47].  
N-7-methylguanine (7MeG), O6-methylguanine (6MeG) and N-3-methyladenine (3MeA) are the 
most abundant DNA base modifications by methyl methane sulfonate (MMS). This method is 
able to discriminate between the two isomeric structure O6-methylguanine and N7-
methylguanine (7MeG) by the two different fragment ions at m/z 134 and 124 respectively, in 
order to identify and quantify the individual methylated DNA bases.  
Individual calibration curves were constructed for each modified base using standard solutions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Effect of methylating agents on Mycobacterium smegmatis cells 
43 
 
 
 
 
 
Figure 13. Calibration curves obtained by using 10, 20, 40, 60, 80 µg/L of methylated standard 
bases: 1) N-3-methyladenine, 2) N-7-methylguanine and 3) O6-methylguanine. 
The MRM transitions used in the analytical method are reported in Table 1. 
1) 
2) 
3) 
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Multiple Reaction Monitoring (MRM) 
Methylated bases Precursor ion (m/z) Fragment ions (m/z) Loss 
O-6-methylguanine 166 
134 
139 
CH3OH 
NH3 
7-methylguanine 166 
124 
149 
NH2CN 
NH3 
3-methyladenine 150 
108 
123 
CH3HCN 
HCN 
 
Table 1: MRM transitions used for quantitative analyses 
 
M.smegmatis cells were grown in the presence and in the absence of MMS. Cells were 
recovered at three different time (3, 6 and 9 hours) to extract genomic DNA samples that were 
acidic hydrolyzed and the released methylated bases submitted to LC-MS/MS analysis in MRM 
scan mode. Figure 14 reported DNA methylation data and cell survival at three different times 
upon exposure to MMS.  
 
 
 
 
Figure 14: DNA methylation of M.smegmatis cells is reported in the presence of MMS in green 
while cellular survival is reported in grey over three different time: 3, 6 and 9 hours upon 
exposure to methylating agent.   
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Quantitative analyses of DNA methylation showed an increasing amount of base modification 
over time demonstrating that increasing DNA methylation induces a proportional widespread 
cellular death. 
 
 
 
3. Bidimensional electrophoresis analyses 
 
 
In order to investigate the global proteomic response to methylation stress, a basic two 
dimensional electrophoresis analysis was carried out.  
M. smegmtis cells were grown in the absence and in the presence of 0.03% MMS and collected 
after 3 hours incubation. Cells were lysated and the protein extracts submitted to a bi-
dimensional electrophoresis (2-D electrophoresis) analysis.  
2-D electrophoresis is a method for the analysis of complex protein mixtures extracted from 
cells, tissues or other biological samples. Proteins are separated according to two independent 
and orthogonal fisico-chemical properties. The first-dimension is an isoelectric focusing (IEF) 
separation of proteins according to their isoelectric points (pI) whereas the second dimension 
consists in an SDS-polyacrylamide gel electrophoresis (SDS-PAGE) that separates proteins 
according to their molecular weights.  
The two gels were stained with colloidal Coomassie and submitted to quantitative image 
analysis using a specific software to evaluate proteins up and down-regulated in the presence of 
MMS.  
Protein spots corresponding to protein differently expressed in the two conditions were excised 
from the gel, in situ digested and the resulting peptide mixtures analyzed by liquid 
chromatography tandem mass spectrometry (LC-MS/MS) approaches that generates data on 
both the accurate molecular mass and the sequence of individual peptides.  
These data were used for database searches using a home version of the Mascot software 
leading to the identification of the proteins. 
These informations were then used to search non-redundant protein databases leading to the 
identification of the protein components. Proteins identified in the proteomic experiments in  
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the absence of methylation stress are listed in table 2 where the protein name, the 
corresponding Swiss Prot code and the number of identified peptides are reported.  
 Protein description Swiss prot 
1 Elongation factor Tu A0QS98 
2 Elongation factor Tu    A0QS98 
3 60 kDa chaperonin 1 A0QQU5 
4 ATP synthase subunit alpha A0R202 
5 Trigger factor A0R199 
6 Elongation factor Ts A0QVB9 
7 F420-dependent glucose-6-phosphate dehydrogenase A0QQJ4 
8 Ferrochelatase A0QX29 
9 ATP synthase subunit b A0R204 
10 NADP-dependent alcohol dehydrogenase C 2 P0CH37 
11 DNA-directed RNA polymerase subunit alpha A0QSL8 
12 NADP-dependent alcohol dehydrogenase C 2 P0CH37 
13 3-oxoacyl-[acyl-carrier-protein] reductase FabG P71534 
14 Acetylornithine aminotransferase A0QYS9 
15 3-oxoacyl-(Acyl-carrier-protein) synthase 1 KasA A0R0B4 
16 Chaperone protein DnaK A0QQC8 
17 Probable monoacyl phosphatidylinositol tetramannoside-
binding protein LpqW 
A0R2I8  
18 Putative succinate-semialdehyde dehydrogenase [NADP(+)] A0R4Q0 
19 Aconitate hydratase A0QX20 
Table 2: Proteins identified in the bi-dimensional analysis. 
 
About twenty differentially expressed proteins were identified in the two conditions. Most of 
the up-regulated proteins following MMS treatment were found to be involved in the cell wall 
components biosynthesis.  
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Particularly, were identified FabG and KasA proteins involved in the fatty acid biosynthesis and 
LpqW protein involved in the LAM synthesis, another cell wall components.  
Also the protein KasA and another identified protein Ef- tu are related with biofilm formation. 
 
 
4. DIGE (Differential In Gel Electrophoresis) 
 
The previous interesting findings were deeply investigated by performing a quantitative 
proteomic analyses using the DIGE technology. 
2D-DIGE is based on fluorescence pre-labeling of protein mixtures before 2D gel electrophoresis. 
Protein samples are each labeled with different dyes, cyanines, that have the same molecular 
weight, but different  excitation/emission value. The labeled proteins are mixed, run together 
and separated simultaneously on the same 2D gel. The images are acquired at the respective 
excitation/emission values. Then the images are superimposed and the resulting map is 
analysed by specific software that carries out the detection and quantification of protein spots. 
The ability to separate more than one sample on a single gel make 2D DIGE a highly 
reproducible technique. And then, the presence of an internal standard and the possibility to 
carry out an unique experiment for every biological replicate improve the accuracy and the 
sensitivity of this technique.  
According to previous results, proteomic experiments were performed after 3 hours of MMS 
treatment. Each culture was divided into two aliquots: one of these was kept as control, and the 
other one was exposed to MMS 0.03%. Following 3 hours incubation, protein lysates from MMS 
treated and untreated cells were extracted and fractionated by bidimensional electrophoresis 
using a 3-10 pH gradient. The spots of interest were picked, in situ hydrolyzed with trypsin and 
the resulting peptide mixtures identified by LC-MS/MS analyses. Mass spectral data were used 
to search a non-redundant protein database by Mascot software. 
A total of 71 differentially expressed proteins were identified in MMS treated M.smegmatis cells 
compared to controls, 28 down and 43 up regulated (table 3). 
 
Fold 
Change 
Protein Gene Swiss Prot 
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-1.14 DNA or RNA helicase of superfamily protein II MSMEG_5706 A0R451 
-1.25 1-deoxy-D-xylulose-5-phosphate synthase dxs A0QW19 
-2,34 Alpha/beta hydrolase MSMEG_0824 A0QQP0 
-2,02 Phosphoenolpyruvate carboxylase ppc A0QWX4 
-2,02 Protein translocase subunit SecA 2 secA2 A0QYG9 
-1.90 Piperideine-6-carboxylic acid dehydrogenase pcd MSMEG_1762 A0QT96 
-1.79 Inosine-5'-monophosphate dehydrogenase guaB A0QSU3 
-1,74 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
-1,61 
Alpha-1,4-glucan:maltose-1-phosphate 
maltosyltransferase 
glgE Q9RP48 
-1,61 Acyl-CoA synthase fad32 MSMEG_6393 A0R618 
-1.60 Uroporphyrinogen decarboxylase hemE A0QW23 
-1,6 Phospho-2-dehydro-3-deoxyheptonate aldolase MSMEG_2799 A0QW41 
-1,56 Sulfate adenylyltransferase subunit 2 cysD A0R242 
-1,56 6-phosphofructokinase PfkA MSMEI_2306 I7G6C4 
-1.55 Isocitrate dehydrogenase icd2 MSMEG_1654 A0QSZ3 
-1,50 3-hydroxyacyl-CoA dehydrogenase fadB MSMEG_5720 A0R465 
-1,47 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
-1,39 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
-1.30 GTP-binding protein TypA typA A0R2J0 
-1,28 Alpha/beta hydrolase MSMEG_0824 A0QQP0 
-1,25 Endopeptidase IV sppA A0QSH0 
-1,25 Uroporphyrinogen-III synthase hemD 0QR19 
-1,17 F420-dependent oxidoreductase MSMEG_5715 A0R461 
-1,17 Adenosine deaminase add A0QT14 
-1,14 1-pyrroline-5-carboxylate dehydrogenase pruA A0R2H8 
-1,14 Fumarate reductase sdhA A0QT08 
-1,13 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
-1,07 Acyl-CoA oxidase MSMEG_4474 A0R0Q9 
1,03 Adenosine deaminase add A0QT14 
1,03 Putative phenylalanine aminotransferase pat A0R5X8 
1,09 ABC-type sugar transport system ATPase component MSMEG_6019 A0R505 
1,15 Acyl-CoA synthase MSMEG_4301 A0R090 
1,15 Fumarate reductase sdhA A0QT08 
1,16 Ribonuclease J rnj MSMEG_2685 A0QVT2 
1,28 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
1,29 Pyruvate dehydrogenase MSMEG_3964 A0QZB5 
1,29 Ribonuclease J rnj MSMEG_2685 A0QVT2 
1,29 60 kDa chaperonin 1 groL1 A0QQU5 
1,29 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
1,30 3-ketoacyl-CoA thiolase fadA2 MSMEG_0373 A0QPE8 
1,32 3-Hydroxyacyl-CoA dehydrogenase MSMEG_5183 A0R2P1 
1,35 D-alanyl-D-alanine dipeptidase vanX MSMEG_5879 A0R4L7 
1,49 Alanine dehydrogenase ald A0QVQ8 
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1,51 Inosine-5'-monophosphate dehydrogenase guaB A0QSU3 
1,56 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
1,58 Inositol-3-phosphate synthase ino1 A0R7G6 
1,63 DNA gyrase subunit B gyrB A0QNE0 
1,67 Divalent metal cation transporter MntH MSMEG_5589 A0R3T6 
1,68 IclR family transcriptional regulator MSMEG_3335 A0QXK4 
1,69 Bifunctional protein GlmU glmU A0R3C7 
1,75 Alkanal monooxygenase alpha chain MSMEG_5029 A0R293 
1,75 4-hydroxy-2-oxovalerate aldolase 2 bbhI-2 MSMEG_5937 A0R4S6 
1,78 Serine/threonine protein kinase MSMEG_5513 A0R3L2 
1,81 Fructose-1,6-bisphosphatase glpX A0R2U7 
1,81 Acetyl-CoA acetyltransferase fadA3 MSMEG_5273 A0R2Y1 
1,81 NADPH:quinone reductase MSMEG_5164 A0R2M2 
1,82 
Ribonucleoside-diphosphate reductase subunit alpha 
1 (nrdE1) MSMEG_1019 P0CG99 
2,17 Acyl-CoA ligase FadD31 MSMEI_4200 I7G4U9 
2,18 Endopeptidase IV sppA A0QSH0 
2,4 3-isopropylmalate dehydratase small subunit leuD MSMEG_2388 A0QUZ0 
2,4 Peptidyl-prolyl cis-trans isomerase ppiA MSMEG_0024 A0QNF6 
2,47 D-ribose-binding periplasmic protein MSMEG_4172 A0QZW4 
3,33 Glycine dehydrogenase (decarboxylating) gcvP A0QYF7 
3,33 DNA polymerase III gamma/tau subunit dnaX MSMEG_6285 A0R5R6 
3,33 Alanine--tRNA ligase alaS A0QWQ4 
4,61 
Conserved hypothetical proline and alanine rich 
protein MSMEG_0067 A0QNJ7 
1,78 
Ribonucleoside-diphosphate reductase subunit alpha 
1 (nrdE1) MSMEG_1019 P0CG99 
1,78 LpqN MSMEI_5361 I7G7W9 
2,32 Chaperone protein DnaK dnaK A0QQC8 
2,17 Acyl-CoA synthase MSMEG_4301 A0R090 
1,33 Carbohydrate kinase FGGY MSMEI_1337 I7F889 
Table 3: Differentially expressed proteins identified 
 
 
The identified proteins were functionally classified according to their known biological functions 
in figure 15.  
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Figure 15: Clustered identified proteins are reported 
 
Most of identified proteins gathered within cell wall processes and metabolic processes. The 
network distributions of 71 differentially expression proteins were explored using STRING 
software (fig 16). 
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Figure 16: Network distribution of the 71 identified protein as obtained by STRING. The stronger 
associations are represented by thicker lines.  
 
Functional investigation showed that some proteins are involved in the same pathways. 
Particularly in table 4 are listed the most interesting protein classes identified by literature 
studies.  
 
Biofilm formation Fatty acid degradation Cell wall biosynthesis 
dnaK fadA2 ald 
gyrB fadA3 vanX 
pknF fadB2 alaS 
ppiA fadD31 glnU 
groL1 fadD32 gcvP 
leuD   
Chapter 3: Effect of methylating agents on Mycobacterium smegmatis cells 
52 
 
 Table 4. Classification of protein identified in according to their biological functions. 
 
 
Proteins involved in biofilm formation are all up regulated in the presence of MMS suggesting a 
physical response to prevent MMS access in the cell environment. The biofilm is an aggregate of 
cells adherent on a surface in a polymeric extracellular matrix. Biofilm formation requires two 
steps: 
1. Adherence of bacterial cells to a surface 
2. Accumulation of multilayered cell clusters 
This bacterial attachment mechanism is required to adhere directly to host organism and it is 
involved in infectious processes for most of pathogen microorganisms.  
 
 
5. Biofilm formation assay 
  
The increasing of proteins involved in biofilm formation in the presence of methylation stress 
was explored by performing specific assay in the presence and in the absence of MMS to 
evaluate the amount of biofilm formed by M.smegmatis. 
Static growth conditions were preliminary optimized in order to accurately evaluate biofilm 
formation. M.smegmatis strain was inoculated on wells in the presence and in the absence of 
0.03% MMS. In vitro quantification of attached cells was determined after 24 hours of 
incubation at 37° C by crystal violet staining and subsequent measurement of the absorbance at 
590 nm. The results are reported in figure 17. 
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Figure 17. Biofilm formation assay in the presence and in the absence of MMS.  
 
 
 
The presence of MMS increased biofilm production compared to untreated cells. This finding 
was in agreement with proteomic results that suggested under stress conditions M. smegmatis 
responses to damaging events increasing physical cellular defense mechanisms 
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1. Homologous expression of Ada-Alka protein 
 
Recombinant expression of the adaptive response protein was carried out homologously in 
M.smegmatis. Cloning strategy was performed in two steps, the first by ligating ada-alkA gene in 
an E.coli vector and the second by cloning into a M.smegmatis expression vector.  
The selected system for cloning was pGEM®-T Easy Vector, a system used to clone directly PCR 
product. This vector is linearized with a single 3’-terminal thymidine at both 5’ and 3’ DNA 
double strand. The presence of two thymidine at the insertion site does not allow the 
circularization of the vector increasing the efficiency of ligation of PCR products. The ada-alkA 
gene was amplified by PCR from MTB genome in order to have a single 3’-terminal adenine at 
both 5’ and 3’ DNA double strand. The ada-alkA gene was hydrolyzed from the recombinant 
pGEM®-T-ada-alkA and cloned into a M. smegmatis vector pMV338. 
M. smegmatis cells were finally transformed with the recombinant plasmid by electroporation 
and then grown to allow the production of recombinant protein obtained as Histidine tagged 
protein. The his-tagged Ada-AlkA was purified by Immobilized Metal Ion Affinity 
Chromatography, exploiting the interaction between the histidine tag on the recombinant 
protein and Ni2+ ions coupled to highly cross-linked agarose beads. SDS- PAGE analysis showed 
that the amount of soluble protein was too low to carry on with further experiments.  
 
2. Heterologous expression of Ada-Alka and Ogt  
Because the homologous expression yield was too low, Ada-AlkA was heterologously expressed 
in E.coli. The gene was cloned into different expression systems: pET22b, pET28a, pET16b and 
pGEX4T1. The highest amount of soluble protein was obtained in pGEX4T1 vector that produced 
Ada-AlkA fused to Glutathione S-transferase (GST). The ada-alkA gene was amplified from MTB 
genome through PCR (fig. 18) and cloned in pGEX4T1 vector containing sequence coding GST 
protein at the N-terminus of the protein.  
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Figure 18: PCR ada-alkA gene from MTB genome 
 
Protein expression was carried out in BL21 E.coli cells in the presence of 0.1mM IPTG induction 
by growing bacterial cells at 20°C for 16 hours.  
Cells were lysed and a specific protocol was used to separate insoluble fraction containing 
inclusion bodies from the soluble fraction. Production and cellular localization of recombinant 
Ada-AlkA were evaluated through SDS-PAGE analysis. Figure 19 shows the gel fractionation of 
total E. coli extract (lane 1), solubilized inclusion bodies (lane 2) and the soluble fraction (lane 3). 
Ada-AlkA was clearly produced in large amount but essentially confined in inclusion bodies.                                               
 
                                              Mk                   1         2       3  
 
 
 
 
 
 
 
 
 
 
 
Figure 19 : SDS-PAGE of the Ada-AlkA production. Total cells extract is loaded in lane 1, inclusion bodies 
in  lane 2 and soluble fraction in lane 3 
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The recombinant protein was purified by affinity chromatography on immobilized glutathione 
beads and hydrolyzed on column to release GST (fig. 20). 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Figure 20: schematic representation of GST affinity chromatography 
 
The eluted proteins were analysed by SDS-PAGE as reported in Figure 21. 
 
Figure 21: Protein purification verified by SDS-PAGE 
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Gel electrophoresis analysis showed that the protein was obtained in a good degree of 
purification, with purified protein concentration of 500 µg/ L of culture. 
The ogt gene was amplified by PCR from MTB genome (fig. 22), cloned in pGEM-T easy system 
and then it was cloned in pGEX4T1 to obtain Ogt protein fused with Glutathione S-Transferase 
(GST). 
 
 
Figure 22 : PCR ogt gene from MTB genome 
 
BL21 E. coli cells were transformed with recombinant plasmid in order to produce recombinant 
Ogt fused with GST.  Bacterial cells were grown at 20°C for 16 hours after induction by 0.1mM 
IPTG. Cells were lysed and the insoluble fraction containing inclusion bodies was separated from 
the soluble fraction. Production and cellular localization of recombinant Ogt were evaluated 
through SDS-PAGE analysis (fig 23). 
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Figure 23 :Gel SDS PAGE. M = marker, 1 = protein extract, 2 = inclusion bodies 3 =soluble fraction 
 
Gel image clearly showed that nevertheless the presence of GST, Ogt was essentially produced 
in inclusion body; however the amount of soluble fraction was enough to carry out further 
experiments. 
Ogt was also purified by GST affinity chromatography and analysed by SDS-PAGE showed in 
figure 24. 
 
 
Figure 24 : Protein purification verified by SDS-PAGE: M = marker, 1 = cellular extract, 2 = 
unbound, 3 = 1 mM GSH elution 
 
The lane 3 clearly shows a band at the expected electrophoretic mobility of about 40 KDa, 
corresponding to presence of Ogt fused with GST (18 KDa + 25 KDa). Bradford assay allowed to 
calculate purified protein concentration that was 3 mg/ L of culture. 
 
3. Structural characterization of Ada-Alka protein 
The aminoacidic sequence of recombinant Ada-Alka was validate using mass spectrometry 
methodologies by MALDI mass mapping. 
Purified protein was analysed by SDS-PAGE and the corresponding protein band was excised 
from the gel, reduced with DTT and alkylated with iodoacetamide to irreversibly block the 
cysteine residues and in situ hydrolyzed with tripsin. The resulting peptide mixture was then 
directly analysed by MALDI-MS using a reflectron instrument. The obtained spectrum is 
reported in figure 25.  
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Figure 25. MALDI TOF spectrum of Ada-AlkA peptide mixture 
 
The accurate mass values of the peptides in the mass spectrum was mapped onto the 
anticipated Ada-AlkA sequence leading to a coverage of the protein primary structure of 90%, as 
reported in figure 26. 
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Figure 26: Recombinant Gst-Ada-AlkA sequence is here reported. In yellow is indicated the 
validated primary  structure. 
 
In order to verify if the recombinant protein was correctly folded circular dichroism analyses was 
performed. Figure 27 shows spectrum obtained both Ada-Alka fused with GST and GST only. 
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Figure 27. Circular dichroism analyses of Gst alone reported in green in comparison with GST-
Ada-AlkA fusion protein in blu.   
 
By comparing two spectra it was evident that the Ada-AlkA is properly structured despite the 
presence of GST, showing both α-helix to β-sheets secondary structure.  
 
 
4. Structural characterization of Ogt protein 
 
The correct primary structure of recombinant Ogt was verified by MALDI mass mapping. Purified 
Ogt was analysed by SDS-PAGE and the corresponding protein band excised from the gel, 
reduced with DTT and alkylated with iodoacetamide and in situ enzymatically digested with 
trypsin. The resulting peptide mixture was then directly analysed by MALDI-MS using a 
reflectron instrument.  
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The obtained spectrum is reported in figure 28. 
 
 
 
 
 
Figure 28. MALDI TOF spectrum of Ogt peptide mixture 
 
 
The accurate mass values of the peptides in the mass spectrum was mapped onto the 
anticipated Ogt sequence leading to a coverage of the protein primary structure of 94%, as 
reported in figure 29. 
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Figure 29. Recombinant Gst-Ogt sequence is here reported. In red is indicated the validated 
primary  structure. 
 
Circular dichroism analyses was performed for both Ogt fused with GST and GST only to verify 
the correct folding of recombinant protein.  
Figure 30 showed that Ogt is correctly folded despite the presence of GST, showing both α-helix 
to β-sheets secondary structure. 
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Figure 30: dichroism analyses of Gst alone reported in green in comparison with GST-Ogt fusion 
protein in blu.   
 
The result obtained was in agreement with the literature data (reference).  
 
 
5. Functional characterization  of Ada-AlkA and Ogt 
 
In order to investigate whether Ada-AlkA and Ogt were able to bind DNA, Elettrophoretic 
Mobility Shift Assay (EMSA) experiments were performed.  
Different amounts of the recombinant proteins were incubated at room temperature with DNA 
double strand probe and protein complexes formation were analysed by agarose gel 
electrophoresis in comparison with the isolated probes. 
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The gel analysis clearly showed an Ada-AlkA-dependent shift in the electrophoresis mobility of 
the DNA-protein complex compared to the isolated probe (fig. 31). These data demonstrated 
that Ada-AlkA protein is capable to bind DNA with non sequence specificity.  
 
                                          
Figure 31: EMSA assay performed on Ada-AlkA protein. DNA alone (0.2 μM) is loaded in the first 
line while DNA-protein complex is in the second one.  
 
Ogt showed a similar behaviour to Ada-AlkA protein, demostrating to be also endowed with 
nonspecific DNA binding cability (fig. 32). 
 
 
Figure 32: EMSA assay performed on Ogt protein. DNA alone (0.2 μM) is loaded in the first line 
while different ratio of protein (10, 50, 80 μM)-DNA complex are present respectively in lanes 2, 
3 and 4.  
 
It was clear that increasing the amount of Ogt increases the shift of the complex, compared to 
isolated probe. 80 mM protein concentration, corresponding to a ratio protein / probe equal to 
400/1 was observed probe saturati 
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1. Molecular partners of the Mycobacterium tuberculosis Ogt protein 
 
 1.1 Isolation of Ogt complexes in Mycobacterium smegmatis upon exposure to MMS 
The elucidation of Ogt biological role at the molecular level was investigated by functional 
proteomics approaches addressed to the identification of protein partners. In fact, multi-protein 
complexes are usually involved in relevant biological mechanisms, so the association of Ogt with 
partners belonging to a particular mechanism will be strongly suggestive of its biological 
function. Isolation of multi-protein complexes was performed using the GST-Ogt fusion protein 
as bait in the presence and in the absence of MMS as methylating agent. 
In vivo isolation of Ogt containing protein complexes was performed in two steps. First, 
M.smegmatis cells were grown in the absence and in the presence of sub-inhibitory 
concentrations of the alkylating agent methyl methane sulfonate. Both cellular pellets were 
lysated in order to obtain Ogt interactors containing protein extracts. Then, E.coli cells producing 
the Ogt-Gst fusion protein were grown to obtain the tagged bait. Cells were lysated and the 
recombinant protein was immobilized on reduced glutathione beads as previously described. 
The total M.smergmatis extracts from the two samples were first submitted to a pre-cleaning 
step by incubation with reduced glutathione immobilized beads in order to remove non-specific 
binding proteins. Then, cellular extracts were incubated with the immobilized Ogt to allow the 
formation of functional protein complexes. After extensive washing the proteins specifically 
bound to Ogt bait were eluted with a buffer containing 1 mM reduced glutathione. Pre-cleaning 
samples were also eluted and used as control. All the samples were fractionated by SDS-PAGE 
and analysed by western blot. Specific incubation with anti Gst antibodies showed the presence 
of the Gst-Ogt bait both in the presence and in the absence of methylating molecules. The 
presence of the bait was not detected in the precleaning elutes representing an internal control 
for the correctness of the pull down experiment as shown in Figure 33. 
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Figure 33. Western blot of Ogt pull down experiments. Lanes 1 and 2 precleaning eluates. Lanes 
3 and 4 Ogt complexes in the absence and in the presence of MMS, respectively. 
 
The pull down experiment resulting SDS-PAGE was stained with Coomassie Blue and is reported 
in Figure 34. 
 
 
Figure 34. Fractionation of Ogt isolated complexes by SDS-PAGE. Lanes 1 and 2 precleaning 
eluates. Lanes 3 and 4 Ogt complexes in the absence and in the presence of MMS, respectively. 
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1.2 Identification of proteins specifically interacting with Ogt 
In order to identify Ogt interactors, the entire lanes of the SDS-PAGE from both samples and 
controls were cut in 23 slices and each gel slice was in situ digested with trypsin and the 
corresponding peptide mixtures directly analysed by LC-MS/MS procedures. The analyses 
provided both accurate molecular weight and sequences of each peptide. These data were used 
for database search using a home version of the Mascot software leading to the identification of 
the proteins. Common proteins identified in both the sample and the control gel slices were 
ruled out and only those solely occurring in the samples were considered as putative Ogt 
interactors thus greatly decreasing the number of false positives.  
Proteins identified in the proteomic experiments in the absence of methylation stress are listed 
in Tables 1 where the protein name, the corresponding Swiss Prot code and the number of 
identified peptides are reported.  
 
Protein  Gene  Swiss Prot  Peptides  
Transcriptional regulator, Ada family protein/DNA-3-
methyladenine glycosylase II  
MSMEG_4925  A0R1Z2  3(2)  
Enoyl-CoA hydratase  MSMEG_4299  A0R088  2(1)  
Transcriptional regulator WhiB  whiB1  A0QTP7  1(1)  
Putative oxidoreductase  MSMEG_1968  A0QTU5  1(1)  
60 kDa chaperonin 1  groL1  A0QQU5  5(2)  
ATP-dependent zinc metalloprotease FtsH  ftsH  A0R588  2(1)  
Pyruvate dehydrogenase E1 component  aceE  A0R0B0  3(1)  
Uncharacterized protein  MSMEI_3028  I7G1A1  2(1)  
Uncharacterized protein  MSMEG_1244  A0QRU7  3(1)  
ABC transporter, permease/ATP-binding protein (exiT)  MSMEG_0018  A0QNF0  2(1)  
Penicillin-binding protein 1A  ponA1  A0R7G2  1(1)  
Bacterial regulatory protein, GntR family protein  MSMEG_0895  A0QQW0  4(2)  
O-succinylhomoserine sulfhydrylase  metZ  A0QQI7  2(1)  
Carboxyl transferase domain protein  MSMEG_2255  A0QUL9  1(1)  
Cytochrome P450  cyp123  A0R5U2  2(2)  
CheR methyltransferase, SAM binding domain protein  cheR  A0R3Q0  5(3)  
Putative aminotransferase  MSMEG_6286  A0R5R7  3(1)  
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Mammalian cell entry protein  MSMEG_1147  A0QRK3  2(1)  
Isocitrate lyase  aceA  A0QYL9  2(1)  
Acyl-CoA oxidase  MSMEG_4474  A0R0Q9  6(3)  
NADH-quinone oxidoreductase subunit B  nuoB  A0QU35  7(2)  
Uncharacterized protein  MSMEG_5168  A0R2M6  7(1)  
5-oxovalerate dehydrogenase  MSMEG_1158  A0QRL4  7(1)  
50S ribosomal protein L7/L12  rplL  A0QS63  7(1)  
30S ribosomal protein S4  rpsD  A0QSL7  6(1)  
Uncharacterized protein  MSMEG_4413  A0R0K0  2(1)  
50S ribosomal protein L18  rplR  A0QSG5  3(1)  
Table 1. Proteins identified in the absence of MMS. 
 
Proteins identified in the proteomic experiments in the presence of methylation stress are listed 
in Tables 2 where the protein name, the corresponding Swiss Prot code and the number of 
identified peptides are reported.  
 
Protein  Gene  Swiss Prot  Peptides  
Putative multifunctional enzyme siroheme synthase Cysg  cobA  A0QVL7  2(1)  
Xylose isomerase  xylA  A0R507  1(1)  
UPF0182 protein MSMEG_1959/MSMEI_1915  MSMEG_1959  A0QTT7  1(1)  
Oxidoreductase, FAD-binding  MSMEG_0295  A0QP72  2(2)  
Succinyl-CoA ligase [ADP-forming] subunit beta  sucC  A0R3M4  2(1)  
Integral membrane protein  MSMEG_5066  A0R2C8  2(1)  
Nitrilase  MSMEG_1120  A0QRH6  2(1)  
Trans-aconitate 2-methyltransferase  tam  A0QQ52  4(1)  
50S ribosomal protein L5  rplE  A0QSG1  2(1)  
ABC transporter binding protein  MSMEG_4762  A0R1I1  1(1)  
Nuclease  MSMEG_0370  A0QPE5  2(1)  
Uncharacterized protein  MSMEI_3829  I7G3X2  2(1)  
Enolase  eno  A0R3B8  4(1)  
ATP-dependent Clp protease ATP-binding subunit ClpX  clpX  A0R196  1(1)  
Endopeptidase IV  sppA  A0QSH0  2(2)  
Error-prone DNA polymerase  dnaE2  A0QSX1  6(1)  
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Urease accessory protein UreG  ureG  A0QRF2  1(1)  
Serine protease  MSMEG_6289  A0R5R9  1(1)  
IS629 transposase orfB  MSMEG_1730  A0QT64  4(1)  
Putative succinate-semialdehyde dehydrogenase 
[NADP(+)]  
gabD2  A0R4Q0  2(1)  
30S ribosomal protein S12  rpsL  A0QS96  1(1)  
2Fe-2S iron-sulfur cluster binding domain protein  MSMEG_1885  A0QTL3  2(1)  
Glucose-1-dehydrogenase  MSMEG_4419  A0R0K6  4(1)  
Acyl-CoA dehydrogenase  MSMEG_4391  A0R0H7  2(1)  
Linalool 8-monooxygenase  MSMEG_3524  A0QY38  1(1)  
Uncharacterized protein  MSMEG_2266  A0QUM9  1(1)  
Iron-dependent peroxidase  MSMEG_6567  A0R6J2  2(1)  
LysR family regulatory protein  MSMEG_0708  A0QQC7  1(1)  
50S ribosomal protein L1  rplA  A0QS46  8(4)  
Uncharacterized protein  MSMEI_5400  I7GED7  7(5)  
Transcriptional regulator, Ada family protein/DNA-3-
methyladenine glycosylase II  
MSMEG_1613  A0QSV3  3(2)  
ABC polar amino acid transporter, inner membrane 
subunit  
MSMEG_3665  A0QYI0  2(1)  
Potassium transporter TrkA  MSMEG_2642  A0QVP1  3(1)  
Uncharacterized protein  MSMEG_4701  A0R1C4  3(1)  
Single-stranded DNA-binding protein  MSMEG_2107  A0QU76  1(1)  
Uncharacterized protein  argS  Q9X5M0  3(1)  
Arginine--tRNA ligase  MSMEG_6238  A0R5L9  1(1)  
Putative two-component system sensor kinase  MSMEG_2487  A0QV88  1(1)  
4-aminobutyrate aminotransferase  MSMEG_1613  A0QSV3  3(2)  
Table 2. Proteins identified in the presence of MMS. 
 
 
1.3 Classification of the identified proteins 
A total of 67 putative partners were identified, 27 in the absence of MMS and 40 in the presence 
of methylating agent. Only the protein Ada-AlkA was identified in both condition while all the 
others were different. According to their reported biological activities, the putative interactors 
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were grouped into different functional categories belonging to metabolism, DNA binding and repair, 
ribosome and membrane components in the absence of MMS and they are listed in Table 3.  
 
 
Metabolism DNA binding and repair Membrane components Ribosome Other 
MSMEG_4299 MSMEG_4925 ftsH rplL groL1 
aceE whiB1 MSMEG_0018 rpsD cheR 
metZ ftsH ponA1 rplR 
 cyp123 MSMEG_0018 nuoB 
  aceA MSMEG_0895 MSMEG_5168 
  MSMEG_4474 
    nuoB 
    MSMEG_1158 
    Table 3. Classification of protein partners identified in the absence of MMS in according to their biological functions 
 
Protein partners classification is graphically reported in the pie chart in Figure 35.  
 
Figure 35. Pie chart showing classification of protein partners identified in the absence of MMS.   
 
In the presence of methylation stress, functional classification of the identified partners showed 
a similar organization except ribosome to that obtained in the absence of MMS. Interactors 
were listed in table 4. 
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Metabolism DNA binding and repair Membrane components Other 
cobA clpX MSMEG_1959 rplE 
xylA dnaE2 MSMEG_5066 rpsL 
sucC ureG MSMEG_4762 MSMEG_3524 
MSMEG_1120 MSMEG_1730 sppA rplA 
eno MSMEG_0708 MSMEG_1613 argS 
gabD2 MSMEG_4925 MSMEG_3665  
otsB MSMEG_4701 MSMEG_6238  
MSMEG_2487    
Table 4. Classification of protein partners identified in the presence of MMS in according to their biological 
functions. 
 
Protein partners classification in the presence of MMS is graphically reported in the pie chart in 
Figure 36. 
 
 
Figure 36. Pie chart showing classification of protein partners identified in the presence of MMS.   
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The network distributions of the 67 putative interactors were explored using STRING software. 
The top-ranked networks were in Ribosome (p-value = 6.86E-5), RNA degradation (p-value 
=9.98E-1) and Alanine, Aspartate and Glutamate metabolism (p-value = 1.26E-1). The obtained 
STRING network is reported in Figure 37. 
 
 
 
Figure 37. Network distribution of the 67 putative interactors identified as obtained by STRING. The 
stronger associations are represented by thicker lines 
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Discussion 
Tuberculosis is an acute infection disease that over 130 years after discover of its causative 
agent MTB, still represents a global health emergency with around 9 million people affected and 
nearly 2 million deaths each year. Despite the progress made in the pathogenesis and therapy, 
TB is one of the leading causes of death worldwide from a single infectious agent [48]. 
Current therapeutic treatment for TB consists in the use of multiple anti-mycobacterial drugs 
such as rifampicin and isoniazid. This treatment is carried out for a long time (6-9 months) 
leading to the onset of drug- and multidrug-resistant strains of MTB, due to the occurrence of in 
vivo mutations derived from the DNA oxidative damage. 
Therefore new therapeutic models are needed to overcome this problem. 
During the infection, if the host immune response is not able to strongly counteract bacterial 
invasion, MTB cells are confined within macrophages and together with different cell types are 
enclosed in a granuloma, a latent infection status without evident clinical manifestations [49, 
50]. During MTB infection, the host antimicrobial response generates several metabolically 
activated DNA alkylating agents leading to severe DNA-damaging injuries on MTB cells [51]. 
Protection of the DNA molecule from chemical damages then strictly depends on the MTB repair 
mechanisms. Recent studies identified an adaptive response mechanism in MTB homologous to 
the same process already described in E.coli. In silico analyses identified in MTB four genes 
which encode the proteins homologous to the components of adaptive response in E. coli. 
Exposure of E. coli to sublethal concentrations of alkylating agents induces the expression of 
four genes (ada, alkA, alkB and aidB) [52]. Expression of these genes is regulated by Ada, that is 
a methyltransferase that also acts as positive regulator of the operon. 
The activation of the genes increases the resistance to the cytotoxic and mutagenic effects of 
alkylating molecules. Unlike E. coli, the DNA repair/protection systems in MBT have not been 
investigated and it is still largely unknown. 
The investigation of the DNA repair and protection mechanisms is really interesting in the 
tuberculosis context because of their involvement in the drug resistant development. Moreover, 
proteins involved in these mechanisms represent excellent putative therapeutic targets to 
explore in search for new TB treatments because of the fundamental role they play for MTB 
viability and due to the absence of homologues in humans. The aim of this thesis project was 
the investigation of the adaptive response of M.tuberculosis to DNA methylation stress and it 
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was divided in three phases. In the first part, cellular response to DNA methylation damage was 
evaluated using M.smegmatis cells, a non pathogenic strain of Mycobacteria. This study was 
carried out by evaluating cellular survival, DNA methylation over time and the global proteomics 
changes in the presence of methylation stress. In the second part, the most interesting proteins 
of the adaptive response were cloned, heterologously expressed in E. coli and structurally and 
functionally characterized. Finally the last part was entirely focused on a functional proteomics 
study of Ogt protein.  
M.smegmatis growths performed in the presence of increasing doses of methylating agent, 
methylmethane sulphonate, showed an extensive and proportional decrease in cell survival in 
comparison with untreated strain. Methylation stress affects cellular life quickly, just after six 
hours corresponding to two generation time. This finding probably is directly related to an 
extensive DNA methylation due to the presence of methylating molecule. Experimental measure 
of DNA bases methylation was performed in order to deeply analyze this point. Tandem mass 
spectrometry analyses were carried out in Multiple Reaction Monitoring mode to quantify 
methylated bases. Obtained data showed an increasing in DNA methylation over time upon 
exposure to methylating molecule with decreasing in M.smegmatis cell survival. This data 
suggest that the cellular responses to DNA alkylation induced by exogenous stress have a 
leading role in the survival and so in the pathogenicity of Mycobacteria. The effect of 
methylating stress on global proteome was investigated by quantitative differential approaches 
in order to investigate this interesting point. In fact over the past decade, proteomics has gained 
an instrumental role within biologic system studies, by enhancing our knowledge of the 
functions of biological networks through the generation of a large amount of information. The 
study of the proteome can be divided into profiling, functional and structural proteomics (53). 
The 2D DIGE (DIfferential In Gel Electrophoresis) technology belongs to the “second generation” 
proteomic techniques, that allow us to evaluate the relative abundance of protein species in two 
different conditions (54). 71 differentially proteins were identified between MMS treated and 
untreated cells. The most of them were up regulated in the presence of methylation stress. 
According to their annotated biological functions, all of them were grouped in some classes. 
Three categories were all up regulated in the presence of MMS gathered within biofilm 
formation, fatty acid degradation and cell wall biosynthesis.  Fatty acid degradation involved 
fadA2, fadA3, fadB2, fadD31, fadD32 while cell wall biosynthesis involved ald, vanX, alaS, glnU, 
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gcvP. M. tuberculosis produces a large range of lipophilic molecules. These molecules comprise 
simple fatty acids such as palmitate and tuberculostearate and very-long-chain, highly complex 
molecules such as mycolic acids and the phenolphthiocerol alcohols. Mycobacteria contain 
examples of every known lipid biosynthetic system, including enzymes usually found in 
mammals and plants as well as the common bacterial systems. The biosynthetic capacity is less 
remarkable than degradative pathways and fatty acid oxidation systems. A total of about 250 
distinct enzymes involved in fatty acid metabolism are present in M. tuberculosis compared with 
only 50 in E. coli (55). Interestingly, because of the wide variability and amount of lipids within 
mammalian cells and the tubercle, Mycobacteria are largely lipolytic rather than lipogenic (56). 
This thesis is also supported by the abundant presence of genes encoding components of fatty 
acid oxidation systems. Moreover the genome of M. tuberculosis contains several enzymes 
belonging to enoyl-CoA hydratase/isomerase superfamily, acyl-CoA synthases and enzymes that 
could catalyse the first step in fatty acid degradation, convert the 3-hydroxy fatty acid into a 3-
keto fatty acid. In addition to this extensive set of dissociated degradative enzymes, the genome 
also encodes the canonical FadA/FadB -oxidation complex.   
 
 
 
Figura 38. Schematic representation of metabolic processes involved in the degradation of fatty 
acids on the host cells together with cell wall biosynthesis  
 
This information highlighted that degradation host-cell lipids is vital in the intracellular life of M. 
tuberculosis. In addition M.tuberculosis take precursors directly from the cell membranes of the 
host for many metabolic processes such as mycobacterial cell-wall constituents. This feature is 
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allowed by an enormous group of -oxidative enzymes capable to produce acetyl CoA useful in 
several reaction of bacterial metabolism. According to above-mentioned literature data, the up 
regulation of both fatty acid degradation and cell wall biosynthesis might suggest that under 
methylation stress conditions M.smegmatis counteracts DNA damages providing fuel to increase 
cellular physical defense. This interesting feature is also support by the up regulation of proteins 
involved in biofilm formation. Bacteria generally exist in one of two types of population: 
planktonic, freely existing in bulk solution, and sessile, as a unit attached to a surface or within 
the confines of a biofilm (57).  A biofilm consists of cells immobilised at a substratum and 
frequently embedded in an organic polymer matrix of microbial origin. A biofilm may be 
described as a microbially derived sessile community characterised by cells that attach to an 
interface, embedded in a matrix of exo-polysaccharide which demonstrates an altered 
phenotype. Biofilm growth is governed by a number of physical, chemical and biological 
processes. Fletcher [42] described the accumulation of microorganisms on a collecting surface 
as a process of three stages: (1) adsorption, or the accumulation of an organism on a collector 
surface i.e. substrate (deposition); (2) attachment, or the consolidation of the interface between 
an organism and a collector, often involving the formation of polymer bridges between the 
organism and collector; (3) colonisation, or growth and division of organisms on the collector’s 
surface. For bacteria, the advantages of biofilm formation are numerous. These advantages 
include protection from antibiotics [58], disinfectants [59], and dynamic environments [60]. 
Intercellular communications within a biofilm rapidly stimulate the up and down regulation of 
gene expression enabling temporal adaptation such as phenotypic variation and the ability to 
survive in nutrient deficient conditions [61]. In GIGE analyses dnaK, gyrB, ppiA, groL1 and leuD 
were identified as involved in biofilm production.  
The molecular chaperone DnaK is important in E.coli for biofilm formation and the chemical 
inhibition of its cellular function is capable to effectively prevent biofilm development. Genetic, 
microbial and microscopic analyses revealed that the lesion of the dnak gene markedly reduced 
the production of the extracellular functional amyloid curli, which contributes to the robustness 
of E.coli biofilm (62).  
The molecular chaperone GroEL1 modulates synthesis of mycolates, long-chain fatty acid 
components of the mycobacterial cell wall, specifically during biofilm formation and physically 
associate with kasA, a key component of the type II fatty acid synthase involved in mycolic acid 
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synthesis. GroEL1 is specifically required for complete growth and biofilm maturation but not for 
initial growth at the liquid-air interface. The possibility of biofilm formation during 
M.tuberculosis infection of mammalian cells remains an unresolved question but could give rise 
to drug-tolerant organisms that persist for long durations of drug treatment (63).  
So biofilm formation could represent a cellular defense of M.smegmatis responding to 
methylation stress. For this reason, biofilm formation assays were performed in the presence 
and in the absence of MMS. Obtained results showed an increasing in biofilm formation upon 
exposure to methylation stress demonstrating a strong correlation between DNA methylation 
and biofilm production.  
In the second part the corresponding gene of Ada-AlkA and Ogt were heterologously expressed 
in E.coli. They were structurally characterized demonstrating the correctness of recombinant 
products in order to use proteins in further functional investigations. In E.coli, Ada acts as 
positive regulator of the mechanism demethylating phosphomethyltriesters in the sugar 
phosphate backbone representing a sensitive regulatory signal leading to Ada operon induction. 
Considering that N-terminal domain of Ada (Ada A) is fused with AlkA and C-terminal domain 
(AdaB) constitutes a separate protein annotated as Ogt, it was interesting investigate whether 
proteins maintained a correlated function. For this reason the protein sensor must be able to 
bind DNA so recombinant products were tested to assess the DNA binding cability by EMSA 
experiments. Obtained results demonstrated that both Ada-AlkA and Ogt were endowed with 
non specific DNA binding capability suggesting that they could work together as the adaptive 
response sensor in the methylation stress.  
In the last part, the biological role of Ogt was analysed by a functional proteomics approach. 
Complete description of the complex network of cellular mechanisms and use of the network to 
predict the full range of cellular behaviors are major goals of systems biology. A key role in 
contemporary biology can be played by functional proteomics, which focuses on the elucidation 
of protein functions and the definition of cellular mechanisms at the molecular level. The 
attainment of these targets is strictly dependent on the identification of individual proteins 
within functional complexes in vivo (64).  
In vivo isolation of Ogt containing protein complexes was performed in order to explore its 
possible role of biological sensor of the mechanism. The experiments was carried out growing 
M.smegmatis cells in the presence and in the absence of sub-inhibitory concentration of MMS. 
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A total of 67 proteins was identified by the proteomic procedure, 40 of which were found under 
methylating stress conditions. The most evident result was the individuation of proteins 
completely different between treated and untreated conditions. The unique protein identified 
both in MMS treated and untreated was Ada-AlkA, part of the adaptive response. This result 
highlighted that Ogt needs to bind Ada-AlkA not only to counteract methylation damages but 
probably also to detect DNA methylation as the sensor of mechanism. Nevertheless bacteria 
evolution separated Ogt and Ada-AlkA genes these findings suggest that the proteins are 
complexed in the adaptive response to methylation stress.     
According to their reported biological activities, identified interactors were grouped into 
different functional categories: Metabolism, DNA binding and repair, Membrane components 
and Ribosome.      
In the presence of MMS, a number of putative interactors involved in pathways strictly 
connected with stress response mechanisms were identified. Particularly, the transcriptional 
regulator TamR, 2 ABC transporter binding protein and Error prone DNA polymerase dnaE were 
identified.  
TamR (trans-aconitate methyltransferase regulator) is a transcriptional regulator that in 
Streptomyces functions in the oxidative stress response to regulate a key step in central 
metabolism (65). Citrate isomerization is an important reaction in both the citric acid and 
glyoxylate cycles, in which citrate is converted to isocitrate by aconitate hydratase (aconitase) 
via the intermediate cis-aconitate (fig. 39). 
 
Figure 39: Citrate isomerization 
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When cis-aconitate is released from the enzyme-substrate complex, it can spontaneously be 
converted to the more stable isomer trans-aconitate. This product represents an inhibitor of 
aconitase, that is a toxic product and its accumulation leads to the inhibition of the citrate 
isomerization step. Trans-aconitate may accumulate during the oxidative stress because the 
aconitase contains a [4Fe-4S] cluster that is essential for catalytic activity, and it is disassembled 
under oxidative stress conditions rendering the enzyme nonfunctional. TamR acts to prevent 
accumulation of trans-aconitate by using it as a substrate to catalyse a methyl group transfer 
from S-adenosyl-methionine (SAM), resulting in formation of the trans-aconitate methylester. 
Esterification of trans-aconitate significantly attenuates its ability to inhibit aconitase and to 
interfere with key steps in central metabolism. Thus, TamR functions in oxidative stress 
responses to alleviate the consequences of aconitase inactivation, probably contributing to 
restore the catalytic function of aconitase by participating in regulating its gene activity and by 
preventing inhibition of functional enzyme by removing the inhibitor trans-aconitate [65]. 
The ABC transporter binding proteins are integral membrane proteins comprising two 
transmembrane domains and two cytoplasmic nucleotide-binding domains; they bind and 
hydrolyse ATP providing energy for uptake or export of substrates across cell membranes. 
Functions include the uptake of nutrients into the cells and the export of virulence factors and 
toxins [66]. The ABC transporter binding protein is able to transfer substances from the outside 
to the inside of the cell and vice versa. It has been reported that in M. smegmatis this protein is 
up-regulated in deficiency of oxygen [67]. Moreover ABC transporter is essential as other 
transporter systems also in the bacterial resistance. In fact, M.tuberculosis is naturally resistant 
to many antibiotics causing drug treatments very difficult. This resistance derived not only from 
the highly hydrophobics cell envelope that represent a permeability barrier but also from other 
structural determinants such as drug efflux system like ABC transporter.  
The Error prone DNA polimerase dnaE is involved in DNA repair. In MTB, under stress conditions, 
DNAE2 is the primary enzyme responsible for adaptive mutagenesis, a mechanism that occurs 
under stress conditions increasing the frequency of appearance of heritable mutations can allow 
the organism to adapt to the environment and relieve selection pressure. It has been suggested 
that pathogenic bacterial strains utilize adaptive mutagenesis to develop resistance against 
therapeutic agents. In fact, it was reported that in MTB, according to this mechanism , DNAE2 
increases the frequency of appearance of mutations allowing pathogenic bacteria to develop 
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drug resistance (68). DNAE2 was found up-regulated in the presence of DNA-damaging agents 
and the loss of this protein reduces survival of MTB after UV irradiation [69]. 
Functional proteomics results highlighted that in the presence of methylating agent Ogt 
interacts with several proteins involved in pathways responding to stress conditions, suggesting 
that the protein could play an essential role also in different cellular responses to methylation 
stress. 
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Abstract: The AidB protein is involved in the adaptive response to DNA alkylation damages in Escherichia coli. Functional 
proteomic experiments were designed to elucidate AidB biological functions in the presence and in the absence of methyl 
methanesulfonate as methylating agent. Several proteins were identified in both conditions and according to their reported biological 
activities, the inter-actors were grouped into three different functional categories: stress response, energetic metabolic pathways and 
nucleic acid metabolism. Particularly, the interaction between AidB and UvrA, a member of the UvrABCD nucleotide excision 
system, suggested a new interesting putative role for AidB. 
 
Key words: AidB protein, adaptive response, UvrA protein, DNA alkylation damages, functional proteomics. 
 
1. Introduction   
DNA modifications by alkyl molecules can cause 
cytotoxic and mutagenic lesions in all living 
organisms. Several repair mechanisms able to remove 
alkyl groups and restore genetic information occur in 
microorganisms to counteract DNA chemical damages. 
Furthermore, bacteria exhibit the adaptive response by 
which cellular resistance enhances with increasing 
doses of methylating agents [1]. This response in 
Escherichia coli involves the presence of the 
acyl-CoA dehydrogenase AidB, among others. AidB 
consists of two domains, the N-terminal region 
responsible of the dehydrogenase activity, and the 
C-terminal domain exhibiting DNA binding capability [2]. 
Unlike all the other proteins of the adaptive response, 
AidB seems to act as a DNA protective protein and it 
is not endowed with DNA repair capabilities.  
Moreover, in the presence of methylating agents, 
AidB allows efficient transcription from promoters 
containing an UP element, AT rich transcription 
enhancer sequences and protects downstream genes 
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from chemical damages [3, 4]. Even though the 
mechanism of DNA protection exerted by AidB is still 
obscure, this protein might prevent alkyl damage 
either by binding and physically hiding the DNA 
molecule or by inactivating alkylating agents thus 
reducing their local concentration.  
This paper focused on the elucidation of AidB 
biological role at the molecular level by functional 
proteomic approaches addressed to the identification 
of AidB protein partners. Since it is now clear that 
relevant biological mechanisms involve multi-protein 
complexes, the association of AidB with partners 
belonging to a particular mechanism will be strongly 
suggestive of its biological function. Isolation of AidB 
multi-protein complexes was performed in vivo by 
pull down strategies using a His-tagged form of the 
protein as bait in the presence and in the absence of 
methyl-methane sulfonate as methylating agent.  
Authors identified several proteins involved in 
different biological mechanisms including various 
response complexes thus suggesting that AidB is 
endowed with different functions indicative of new 
cellular strategies to counteract alkylation stresses. 
DAVID  PUBLISHING 
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2. Experimental Sections 
Proteomic grade trypsin, DTT (dithiothreitol), 
HEPES, KCl, MgCl2, glycerol, ammonium 
bicarbonate and triton were purchased from Sigma. 
All used solvents were of the highest purity available 
from Romil. 
2.1 Escherichia Coli Growths and Cell Extraction 
Preparation 
E. coli cells growths were transformed with the 
construct pET22b-AidB. Bacterial culture was grown 
overnight in LB medium at 37 °C and it was diluted 
1:100 in fresh medium containing ampicillin (100 
µg/mL) and riboflavin (100 µM). At an A600 nm of 0.4, 
the culture was divided in two aliquots and one of 
these was supplemented with 0.04% MMS (methyl 
methane sulfonate) that has been shown to induce the 
adaptive response. After one cell duplication cellular 
pellets were collected. The cells were resuspended in 
20 mM Na2HPO4, 20 mM Imidazole, 500 mM NaCl, 
1 mM PMSF (phenil methane sulphonyl fluoride) (pH 
= 7.4), disrupted by passage through a french press 
and centrifuged at centrifugal force of 14,000 x g for 
15 min at 4 °C. The supernatant was collected and 
protein concentration was determined with the 
Bio-Rad protein assay, using bovine serum albumine 
as standard.  
2.2 Pull-Down Experiments 
Isolation of AidB partners complex was performed 
by using His-SelectTM Nickel (Sigma) containing 
Ni2+ ions immobilized to bind His-tagged AidB. A 
control was carried out in order to discriminate 
between proteins that interact specifically with the 
Ni2+ compared to those that bind in a nonspecific 
manner to the resin. For this reason, the stripping of 
the resin was executed by washing in 20 mM sodium 
phosphate, 0.5 M NaCl and 50 mM EDTA, for the 
purpose of removing Ni2+ ions. In this way, the resin 
lost the ability to interact specifically with the tag of 
histidines, but it was still able to establish nonspecific 
interactions. At this point, the resin was washed with 
20 mM sodium phosphate, 0.5 M NaCl and 20 mM 
imidazole pH 7.4. The two protein extracts (2.5 mg) 
were incubated for 16 h at 4 °C with 100 μL of resin 
without nickel ions in the precleaning step. The 
extracts were then recovered and incubated with 
His-SelectTM Nickel resin for 16 h at 4 °C to bind 
AidB by tag of histidines and to isolate its complexes. 
Both the precleaning and affinity chromatography 
resins were recovered and washed with 20 mM 
sodium phosphate, 0.5 M NaCl and 20 mM imidazole 
pH 7.4. The elution was performed with sample buffer. 
The samples were then subjected to SDS-PAGE 
(SDS-polyacrilamide gel electrophoresis). 
2.3 In Situ Digestion  
Protein bands stained with Coomassie brilliant blue 
were excised from the gel and destained by repetitive 
washes with 0.1 M NH4HCO3 (pH 7.5) and 
acetonitrile. Samples were reduced by incubation with 
50 µL of 10 mM DTT in 0.1 M NH4HCO3 buffer (pH 
7.5) and alkylated with 50 µL of 55 mM 
iodoacetamide in the same buffer. Enzymatic 
digestion was carried out with trypsin (12.5 ng/µL) in 
10 mM ammonium bicarbonate (pH 7.8). Gel pieces 
were incubated at 4 °C for 2 h. Trypsin solution was 
then removed and a new aliquot of the digestion 
solution was added; samples were incubated for 18 h 
at 37 °C. A minimum reaction volume was used as to 
obtain the complete rehydratation of the gel. Peptides 
were then extracted by washing the gel particles with 
10 mM ammonium bicarbonate and 1% formic acid in 
50% acetonitrile at room temperature. 
2.4 LC/MS/MS (Liquid Chromatography Tandem 
Mass Spectrometry) Analyses 
Tryptic peptide mixtures obtained from in situ 
digestions were analysed by LC/MS/MS using an 
HPLC-Chip/Q-TOF 6520 (Agilent Technologies). 
The peptide mixtures were injected by auto sampler. 
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They were sent to the enrichment column of the chip 
at flow rate of 4 μL/min, in 98% water, 2% 
acetonitrile and 0.1% formic acid. Subsequently the 
peptides were eluted directly into the capillary column 
(C18 reversed phase), at a flow rate of 0.4 μL/min. 
The chromatographic separation was carried out with 
a linear gradient in 95% acetonitrile, 5% water and 
0.1% formic acid. The eluate was then introduced in 
the ESI source for the tandem analysis. In this way 
each mass spectrum (range 300-2,400 m/z) was 
followed by one or more tandem mass spectra (range 
100-2,000 m/z), obtained by fragmenting the most 
intense ions in each fraction eluted chromatographic. 
The acquired MS/MS spectra were transformed in 
Mascot generic file format and used for peptides 
identification with a licensed version of MASCOT 
(modular approach to software construction, operation 
and test, matix science, USA), in a local database. 
2.5 Construction of Expression Vectors 
The bacterial strains and plasmids used in this work 
are all reported in Table 1. The UvrA, DeaD, RecA, 
TnaA and Ada genes of E. coli K12 were amplified 
from genomic DNA by PCR (polymerase chain 
reaction). To obtain proteins tagged with c-myc 
epitope, the corresponding amplification products 
were digested with BamHI and XhoI and cloned into 
the pET22b-c-myc vector [4], respectively. All 
plasmids (Table 1) containing the coding sequence for 
the corresponding recombinant protein fused to a 6X 
histidine tag to facilitate protein purification by Ni2+ 
affinity chromatography. Plasmids construction was 
verified by automated DNA sequencing. 
2.6 Production and Purification of Recombinant 
Proteins 
Recombinant cells were grown at 37 °C to an OD 
(optical density) at 600 nm of about 0.5, at which time 
0.05 mM isopropyl-beta-D-thiogalactopyranoside 
(IPTG) was added in order to express UvrA, DeaD, 
RecA, TnaA and Ada genes. Selective antibiotic was 
used at concentration of 100 µg/mL ampicillin. After 
incubation, cells were harvested by centrifugation at 
centrifugal force of 5,000 x g for 15 min at 4 °C, 
resuspended in 50 mM Na2HPO4, 20 mM Imidazole, 
500 mM NaCl, 1 mM PMSF (pH 7.4), disrupted by 
passage through a French press and centrifuged at 
centrifugal force of 14,000 x g for 30 min at 4 °C. 
Recombinant proteins were purified by affinity 
chromatography on His-Select Nickel Affinity Gel 
(Sigma). After 1 min of incubation at 4 °C, the matrix 
was collected by centrifugation at centrifugal force of 
11,000 x g for 1 min and washed three times with 
same equilibration buffer. The recombinant proteins 
were eluted with buffer containing 500 mM imidazole 
in 20 mM Na2HPO4, pH 7.4, 0.5 M NaCl. 
Protein concentration was estimated with Bradford 
reagent  (Bio- Rad protein assay)  and  protein  content 
 
Table 1  Bacterial strains and plasmids used. 
Strains/plasmids Description Reference or source 
Strains 
C41 (DE3) 
Strain that derives from BL21 [F-ompT hsdSB (rB-mB-) gal dcm (DE3)]. This strain 
has at least one uncharacterized mutation that prevents cell death associated with 
expression of many toxic recombinant proteins. 
Ref. [3] 
Plasmids 
pET22b(+)  
Carries an N-terminal pelB signal sequence for potential periplasmic localization, 
plus an optional C-terminal His-tag sequence 
Novagen 
pET22b-Ada pET22bΔ(BamHI-XhoI)Ω(Ada gene)   This work 
pET22b-DeaD pET22bΔ(BamHI-XhoI)Ω(DeaD gene)   This work 
pET22b-TnaA pET22bΔ(BamHI-XhoI)Ω(TnaA gene)   This work 
pET22b-UvrA pET22bΔ(BamHI-XhoI)Ω(UvrA gene)   This work 
pET22b-RecA pET22bΔ(BamHI-XhoI)Ω(RecA gene)   This work 
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was checked by SDS-PAGE. 
2.7 Co-Immunoprecipitation and Western Blotting 
For co-immunoprecipitations, E. coli strain C41 
(DE3) was transformed with the following constructs: 
pET22b-c-myc-Ada, pET22b-c-myc-TnaA, pET22b-c 
-myc-DeaD, pET22b-c-myc-RecA and pET22b-c-myc 
-UvrA. After expression of the recombinant genes 
without induction, cells were harvested, suspended in 
50 mM Na2HPO4 (pH 7.4), disrupted by passage 
through a French press and centrifuged at centrifugal 
force of 14,000 x g for 30 min at 4 °C. The 
supernatants were used for the 
co-immunoprecipitation experiments.  
Cell lysates (0.5 mg) were incubated with 
agarose-linked c-myc antibody (Bethyl) and with 
agarose beads only (control of the experiment) at 4°C 
overnight. The beads were then collected by 
centrifugation. Precipitates were washed several times, 
the bound proteins were eluted with 1 × SDS-PAGE 
sample buffer and subjected to SDS-PAGE followed 
by Western Blot Analysis that was performed by 
using anti-AidB antibody (Primm, Milano Italy) and 
anti-c-myc mouse antibody (Calbiochem) as first 
antibodies and anti-mouse IgG conjugated to 
peroxidase as a secondary antibody (Calbiochem).  
3. Results and Discussion 
3.1 Isolation of AidB Complexes in E. coli Upon 
Exposure to MMS 
In vivo isolation of AidB containing protein 
complexes were performed by transforming E. coli 
C41 strain with the pET22b-AidB construct carrying 
the AidB gene fused to a six histidine tags. The strain 
was grown in the absence and in the presence of 
sub-inhibitory concentrations of the alkylating agent 
MMS. Isolation of AidB complexes was performed by 
IMAC (ion metal affinity chromatography). The total 
protein extracts from the two samples were first 
submitted to a pre-cleaning step by incubation with 
His-Select beads lacking nickel ions in order to 
remove non-specific proteins. Eluates from the 
pre-cleaning were then recovered and AidB containing 
complexes were isolated by IMAC on His Select 
beads. After extensive washing, the proteins 
specifically bound to AidB bait were eluted with a 
strong ionic buffer containing 0.5 M imidazole and 
fractionated on SDS-PAGE stained with coomassie 
blue. Pre-cleaning samples were also eluted and used 
as control. Fig. 1 shows the obtained Coomassie black 
stained gel.  
3.2 Identification of Proteins Specifically Interacting 
with AidB 
The entire lanes from both samples (3, 4) and 
controls (1, 2) were cut in 24 slices and each gel slice 
was in situ digested with trypsin and the 
corresponding peptide mixtures directly analysed by 
LC/MS/MS procedures. Tandem mass spectral 
analyses provided both the accurate molecular mass 
and sequence information from the daughter ion 
spectra of each peptide. These data were used for 
database searches using a home version of the Mascot 
 
Fig. 1  SDS-PAGE fractionation of AidB complexes. Lanes 
1 and 2 precleaning eluates. Lanes 3 and 4 AidB complexes 
in the absence and in the presence of MMS, respectively. 
Molecular Partners of Escherichia coli Transcriptional Modulator AidB 
  
880
software leading to the identification of the proteins. 
Common proteins identified in both the sample and 
the control gel slices were ruled out and only those 
solely occurring in the samples were considered as 
putative AidB inter-actors thus greatly decreasing the 
number of false positives. Proteins identified in the 
proteomic experiments are listed in Tables 2 and 3 
where the protein name, the corresponding Swiss Prot 
code and the number of identified peptides are 
reported. The presence of the AidB bait in both lists 
constituted a sort of internal control indicating the 
correctness of the pull down experiment.  
A total of 73 kinds of proteins were identified by 
the proteomic procedure, 17 of which were found both 
in the presence and in the absence of the methylating 
proteomic experiments are summarized in Tables 2 
and 3. According to their reported biological activities, 
these identified inter-actors were grouped into 
different functional categories: metabolic pathways 
including several FAD and NAD+ dependent 
dehydrogenases, stress response and transcription, 
translation and processing of DNA/RNA. Among 
others, we focused our attention on the stress response 
proteins for further investigations.  
3.3 Validation of Protein-protein Interactions by 
Co-immunoprecipitation Experiments 
Putative protein-protein interactions detected by the 
proteomic experiments were validated by 
co-immunoprecipitation experiments. Proteins 
involved in pathways strictly connected with DNA 
repair and protection mechanisms were firstly 
examined. Each putative protein partner was 
recombinantly expressed as c-myc-tagged protein in E. 
coli C41 cells and the cell extracts were 
immunoprecipitated with anti-c-myc-conjugated 
antibody. Immunoprecipitates were fractionated    
by SDS-PAGE and stained by Western  blot  analysis 
 
Table 2  Proteins identified in the control sample. 
In the absence of MMS Swiss prot code Peptides 
2-oxoglutarate dehydrogenase E1 component (SucA) P0AFG3 2 
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex (AceF) P06959 6 
Phosphoenolpyruvate synthase (PpsA) P23538 2 
Bifunctional polymyxin resistance protein arnA (ArnA) P77398 42 
Glucosamine-fructose-6-phosphate aminotransferase [isomerizing] (GlmS) P17169 10 
Phosphoenolpyruvate-protein phosphotransferase (PtsI) P08839 3 
Protein AidB P33224 20 
Alkyl hydroperoxide reductase subunit F (AhpF) P35340 7 
Glycogen synthase (GlgA) POA6U8 11 
UDP-N-acetylmuramate: L-alanyl-gamma-D-glutamyl-meso-diaminopimelate ligase (mpl) P37773 2 
NADP-specific glutamate dehydrogenase (gdhA) P00370 12 
3-oxoacyl-[acyl-carrier-protein] synthase 2 (fabF) P0AAI5 3 
Transcriptional activator protein (lysR) P03030 9 
Ribosomal small subunit pseudouridine synthase A (rsuA) P0AA43 11 
UPF0011 protein yraL (yhbJ) P67087 6 
Enoyl-[acyl-carrier-protein] reductase [NADH] (fabI) P0AEK4 2 
Acyl-[acyl-carrier-protein]-UDP-N-acetylglucosamine O-acyltransferase (lpxA) P0A722 2 
FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase (fklB) P0A9L3 6 
Catabolite gene activator (crp) P0ACJ8 22 
UPF0011 protein yraL (yraL) P67087 2 
Uncharacterized protein yqjI (yqjI) P64588 3 
Uncharacterized protein ybgA (ybgA) P24252 2 
Ferric uptake regulation protein (fur) P0A9A9 6 
50S ribosomal protein L17 (rplQ) P0AG44 3 
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Table 3  Proteins identified in the sample treated with 0.04% MMS. 
In the presence of MMS Swiss prot code Peptides 
UvrABC system protein A (UvrA) P0A698 5 
Aldehyde-alcohol dehydrogenase (AdhE) P0A9Q7 2 
Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex 
(AceF) P06959 5 
Ribonucleoside-diphosphate reductase 1 subunit alpha (NrdA) P00452 3 
Maltodextrin phosphorylase (malP) P00490 2 
Bifunctional polymyxin resistance protein arnA (arnA) P77398 37 
Glucosamine-fructose-6-phosphate aminotransferase [isomerizing] (glmS) P17169 20 
Phosphoenolpyruvate-protein phosphotransferase (ptsI) P08839 7 
Cold-shock DEAD box protein A (DeaD) P0A9P6 6 
Succinate dehydrogenase flavoprotein subunit (sdhA) P0AC41 3 
GTP-binding protein typA/BipA (typA) P32132 2 
L-aspartate oxidase (NadB) P10902 2 
Chaperone protein hscA (hscA) P0A6Z1 2 
D-lactate dehydrogenase (dld) P06149 2 
Protein aidB (AidB) P33224 19 
Alkyl hydroperoxide reductase subunit F (ahpF) P35340 9 
Glucose-6-phosphate 1-dehydrogenase (zwf) P0AC53 3 
Glycogen synthase (glgA) POA6U8 10 
UDP-N-acetylmuramate: L-alanyl-gamma-D-glutamyl-meso-diaminopimelate ligase (mpl) P37773 3 
Tryptophanase (TnaA) P0A853 2 
NADP-specific glutamate dehydrogenase (gdhA) P00370 24 
3-oxoacyl-[acyl-carrier-protein] synthase 2 (fabF) P0AAI5 4 
3-oxoacyl-[acyl-carrier-protein] synthase 1 (fabB) P0A953 5 
Succinylornithine transaminase (astC) P77581 13 
UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) P0A749 11 
Glutamate-1-semialdehyde 2,1-aminomutase (hemL) P23893 4 
S-adenosylmethionine synthetase (metK) P0A817 5 
Protein hflK (hflK) P0ABC7 4 
Isocitrate dehydrogenase [NADP] (icd) P08200 2 
Maltose/maltodextrin import ATP-binding protein malK (malK) P68187 4 
Transcription termination factor rho (rho) P0AG30 3 
ATP-dependent Clp protease ATP-binding subunit clpX (clpX) P0A6H1 3 
Cysteine desulfurase (iscS) P0A6B8 3 
Regulatory protein ada (ada) P06134 9 
Glycerol dehydrogenase (glda) P0A9S5 3 
Acetylornithine deacetylase (arge) P23908 4 
Lactose operon repressor (laci) P03023 3 
Glutamate-1-semialdehyde 2,1-aminomutase (gsa) P23893 2 
USG-1 protein (usg) P08390 2 
Riboflavin biosynthesis protein RibD (RibD) P25539 4 
P-protein (pheA) P0A9J8 3 
UDP-4-amino-4-deoxy-L-arabinose—oxoglutarate aminotransferase (ArnB) P77690 3 
Glyceraldehyde-3-phosphate dehydrogenase A (gabA) P0A9B2 13 
Elongation factor Ts (tsf) P0A6P1 8 
UPF0042 nucleotide-binding protein yhbJ (yhbJ) P0A894 6 
Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) P0A9Q5 2 
Aspartate carbamoyltransferase catalytic chain (pyrB) P0A786 2 
Ribosomal small subunit pseudouridine synthase A (rsuA) P0AA43 12 
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(Table 3 continued) 
In the presence of MMS Swiss Prot code Peptides 
Uncharacterized HTH-type transcriptional regulator yeiE (yeiE) P0ACR4 10 
UPF0042 nucleotide-binding protein yhbJ (yhbJ) P0A894 11 
Formyltetrahydrofolate deformylase (purU) P0A440 10 
UPF0011 protein yraL (yraL) P67087 7 
Enoyl-[acyl-carrier-protein] reductase [NADH] (fabI) P0AEK4 2 
Acyl-[acyl-carrier-protein]-UDP-N-acetylglucosamine O-acyltransferase (lpxA) P0A722 3 
D-methionine-binding lipoprotein metQ (metQ) P28635 2 
FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase (fklB) P0A9L3 6 
GTP cyclohydrolase 1 (folE) P0A6T5 2 
Catabolite gene activator (crp) P0ACJ8 21 
Translation initiation factor IF-3 (infC) P0A707 2 
Uncharacterized protein yqjI (yqjI) P64588 3 
UPF0227 protein ycfP (ycfP) P0A8E1 3 
50S ribosomal protein L6 (rplF) P0AG55 2 
UPF0304 protein yfbU (yfbU) P0A8W8 2 
Ferric uptake regulation protein (fur) P0A9A9 8 
50S ribosomal protein L27 (rpmA) P0A7L8 2 
30S ribosomal protein S15 (rpsO) P0ADZ4 3 
 
using an anti-AidB antibody. Interaction of the 
individual partner with AidB was confirmed by the 
presence of a positive signal revealed by the western 
blot analysis. 
As an example, Fig. 2 shows the Western Blot 
Analysis performed on the immunoprecipitate from E. 
coli cells expressing c-myc tagged UvrA. Fig. 2a 
shows the total cell extract (lane 1) and the 
corresponding immunoprecipitate (lane 3) 
immunorevealed by anti c-myc antibody 
demonstrating that UvrA was expressed by the 
recombinant cells and immunoprecipitated by the 
antibody. Fig. 2b shows the positive signal detected 
when the UvrA immunoprecipitate was incubated 
with the anti-AidB antibody, demonstrating the 
presence of AidB in the sample and confirming the 
interaction.  
Positive interactions of AidB with UvrA, DeaD and 
TnaA were identified, whereas no positive bands in 
the western blot could be detected when Ada and 
RecA proteins were tested.  
It should be underlined that both Cold-shock DEAD 
box protein A (DeaD) and Tryptophanase (TnaA) had 
already been identified in complex with AidB in the 
transcriptional machinery gathered at the E. coli arnB 
P1 promoter in the presence of MMS [4]. 
3.4 Discussion 
The biological mechanism underlying the adaptive 
response to DNA alkylation damages in E. coli was 
extensively described. Sub inhibitory concentration   
of methylating agents  induces the  expression  of  four 
 
 
(a) 
 
(b) 
Fig. 2  (a) Western blot analysis of the total cell extract 
from E. coli C41 cells producing c-myc-UvrA (lane 1) and 
the UvrA containing immunoprecipitate (lane 3). Lane 2 
contains the precleaning; (b) Western blot analysis of the 
total cell extract from E. coli C41 cells (lane 1) and the 
UvrA immunoprecipitate revealed by the anti-AidB 
antibody (lane 3). Lane 2, precleaning. 
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genes (Ada, AlkA, AlkB, AidB) involved in the direct 
repair of DNA alkylation damages. While the role of 
the first three proteins, Ada, AlkA and AlkB, was 
clearly defined [5], the involvement of AidB in this 
system has long been known but its specific role in the 
protection/repair of DNA is still obscure. Previous 
data demonstrate that AidB interacts with DNA very 
likely to protect the nucleic acid from alkylating 
molecules but it is not able to repair the DNA 
molecule following alkylation [4]. In addition, the 
protective action of AidB is preferentially expressed 
on DNA regions containing upstream elements. This 
observation led to the hypothesis that AidB might 
belong to a putative pathway of degradation of 
alkylating agents through its FAD dependent 
dehydrogenase activity. Alternatively, AidB might 
protect these DNA regions by physically interact with 
them thus impairing the dangerous action of alkylating 
agents. 
Proteomic approaches were designed to shed some 
light on the mechanism of action of AidB through the 
identification of its protein partners in vivo. AidB 
partners were isolated by immunoprecipitation 
procedures both in the absence and in the presence of 
MMS as alkylating agent and the individual protein 
components identified by mass spectrometry. Several 
proteins were identified in both conditions, although 
the number of AidB molecular partners is 
considerably higher in the presence than in the 
absence of MMS.  
Proteins identified under methylating stress 
conditions were grouped in three large categories 
according to their reported biological activities, stress 
response, energetic metabolic pathways, and nucleic 
acid metabolism (transcription, processing and 
translation). In particular, AidB was found to interact 
with UvrA whose expression is under the control of 
the SOS response system involved in DNA damages 
response [6]. This interaction was also validated by 
co-immunoprecipitation experiments confirming 
proteomic data. Interaction of these two proteins is 
very interesting since UvrA is part of the UvrABCD 
nucleotide excision system involved in removing 
modified nucleotides as a result of several different 
DNA modifications including formation of covalent 
bonds, local unfolding, abnormal folds and variations 
in charge distribution [7]. UvrA works in a 
multienzyme complex with the specific role of 
examining the DNA molecule in search for 
modifications in order to allow the other proteins of 
the complex to perform the excision of the damaged 
nucleotides [8]. This protein is generally present at 
very low concentrations within the cell but its 
expression strongly increases under stress conditions 
[9]. Interaction of AidB with UvrA might then 
indicate that AidB is involved in different response 
complexes other than the Ada-dependent adaptive 
mechanism, suggesting new cellular strategies to 
minimize DNA damages.  
In the presence of MMS, several other proteins 
belonging to metabolic pathways were identified 
suggesting a general mechanism of energy production 
developed by E. coli to counteract stress conditions. 
Among these, many AidB inter-actors are involved in 
the biosynthesis of fatty acids, indicating the 
occurrence of a possible mechanism of cell wall repair. 
It is likely, in fact, that besides DNA modifications, 
alkylating agents might produce damages to cell wall 
components thus inducing a specific response from 
the microorganism that enhances the metabolic 
synthesis of fatty acids in an attempt to repair or 
replace damaged membrane components thus 
strengthening the physical defenses of the cell. 
4. Conclusions 
In conclusion, the data reported in this paper 
identified a novel interaction between AidB and UvrA 
which is a component of the UvrABCD system 
involved in DNA repair under several stress 
conditions delineating a new possible role for the 
AidB protein. Moreover, the identification of several 
proteins belonging to the fatty acid biosynthetic 
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pathway as AidB partners pointed out to a mechanism 
of cell wall consolidation as a new defense strategy of 
the cell against the poisonous effect of methylating 
agents.  
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